People_

Professor Kristine Macartney

Professor
Paediatrics and Child Health
Children's Hospital, Westmead
Director
National Centre for Immunisation Research and Surveillance (NCIRS)

Websites

Biographical details

Professor Kristine Macartney is a paediatrician specialising in infectious diseases and vaccinology She is a medical graduate of the University of New South Wales and undertook her specialty training in Sydney and in the United States at the Children’s Hospital of Philadelphia. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates. She was a foundational member of the Vaccine Education Center at the Children’s Hospital of Philadelphia. Kristine is currently the Director of the National Centre for Immunisation Research and Surveillance (NCIRS), a paediatric infectious disease consultant at The Children’s Hospital at Westmead and a Professor in the Discipline of Paediatrics and Child Health, University of Sydney. Her research interests include translation of evidence into policy and practice, vaccine safety, and most other areas of vaccine preventable diseases research, particularly in relation to rotavirus, varicella zoster virus and influenza. She is the senior editor of the Australian Immunisation Handbook (9th and10th Editions and online) and has authored >200 peer-reviewed publications. She is a member of the Advisory Committee on Vaccines (ACV) of the Therapeutic Goods Administration (TGA), the Communicable Diseases Network of Australia (CDNA) and the Australian Technical Advisory Group on Immunisation (ATAGI). She has acted as an expert consultant to the World Health Organisation (WHO) and is a member of the WHO Global Advisory Committee on Vaccine Safety (GACVS).Kristine leads the Australian national AusVaxSafety and Paediatric Active Enhanced Disease Surveillance (PAEDS) networks, and is the founding chair of the Australian Regional Immunisation Alliance (ARIA).

Themes

Infection and Immunological Conditions

Keywords

Infection and immunity

Clinical speciality

Paediatrics

Current research students

Project title	Research student
Exploring wealth inequalities in immunisation in the Philippines.	Carlo LORENZO

Publications

By Type

Expand all

Book Chapters

Macartney, K., Crawford, N. (2017). Management and prevention of infectious diseases in IBD patients. In Daniel C. Baumgart (Eds.), Crohn's disease and ulcerative colitis: From epidemiology and immunobiology to a rational diagnostic and therapeutic approach. 2nd ed. Cham: Springer International Publishing. [More Information]
McIntyre, P., Macartney, K., Gilroy, N., Lester, R. (2010). Immunisation. In A Yung, D Spelman, A Street, J McCormack, T Sorrell, P Johnson (Eds.), Infectious Diseases: A clinical approach, (pp. 648-666). Melbourne: IP Communications.

Journals

Jayasinghe, S., Williams, P., Macartney, K., Crawford, N., Blyth, C. (2025). Assessing the impact of pneumococcal conjugate vaccine immunisation schedule change from 3+0 to 2+1 in Australian children: A retrospective observational study (In Press). Clinical Infectious Diseases, 80(1), 207-214. [More Information]
Nguyen, T., Dawes, L., Huang, Y., Tay, E., Dymock, M., O’Moore, M., King, C., Macartney, K., Wood, N., Deng, L. (2025). Short term safety profile of respiratory syncytial virus vaccine in adults aged ≥ 60 years in Australia. The Lancet Regional Health. Western Pacific, 56(101506), 1-3. [More Information]
Sonneveld, N., Jackson, J., Dey, A., Lambert, S., Clark, K., Cowie, B., Macartney, K., Beard, F. (2024). Australian vaccine preventable disease epidemiological review series: Hepatitis B, 2000-2019. Communicable Diseases Intelligence, 48. [More Information]
Faksova, K., Grange, Z., Escolano, S., Sepulveda, G., Shetty, A., Pillsbury, A., Sullivan, C., Naveed, Z., Janjua, N., Giglio, N., Gidding, H., Macartney, K., et al (2024). COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine, 42(9), 2200-2211. [More Information]
Koirala, A., Winkler, N., Sharpe, C., van Tussenbroek, T., Wood, P., Macartney, K., Quinn, H. (2024). Real-world utilisation of SARS-CoV-2 rapid antigen testing to enable face-to-face learning in Australian schools, an ecological study. Australian and New Zealand Journal of Public Health, 48(3), 100159. [More Information]
Imai, C., Jayasinghe, S., McRae, J., Li-Kim-Moy, J., Chiu, C., Macartney, K., Burns, P., Cooper, K., Cheng, A., Gibney, K., Jones, C., et al (2024). Surveillance of adverse events following immunisation in Australia annual report, 2021. Communicable Diseases Intelligence, 48. [More Information]
Glover, C., Deng, L., Larter, C., Brogan, C., Richardson, O., Huang, Y., Kay, E., Macartney, K., Wood, N. (2024). Surveillance of adverse events following immunisation in Australia annual report, 2021. Communicable Diseases Intelligence, 48. [More Information]
Glover, C., Deng, L., Larter, C., Brogan, C., Richardson, O., Huang, Y., Kay, E., Macartney, K., Wood, N. (2024). Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021. Communicable Diseases Intelligence, 48. [More Information]
Baldwin, Z., Hope, K., Glasgow, K., Hueston, L., Roberts-Witteveen, A., Stanley, P., Sheel, M., Winkler, N., Koirala, A., Macartney, K., et al (2024). The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross-sectional serosurvey. Medical Journal of Australia, 220(11), 561-565. [More Information]
Ramsay, J., Jones, M., Vande More, A., Hunt, S., Williams, P., Messer, M., Wood, N., Macartney, K., Lee, F., Britton, W., Snelling, T., Caterson, I. (2023). A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study). Vaccine, 41(48), 7250-7258. [More Information]
Hull, B., Hendry, A., Dey, A., Brotherton, J., Macartney, K., Beard, F. (2023). Annual immunisation coverage report 2021. Communicable Diseases Intelligence, 47. [More Information]
Pillsbury, A., Phillips, A., Deng, L., Quinn, H., Macartney, K., Gidding, H. (2023). Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines. Vaccine, 41(22), 3422-3428. [More Information]
Liu, B., Stepien, S., Qian, J., Gidding, H., Nicolopoulos, K., Amin, J., Cheng, A., Macartney, K. (2023). Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection. Vaccine, 41(38), 5587-5591. [More Information]
Davies, C., Marshall, H., Brotherton, J., McCaffery, K., Kang, M., Macartney, K., Garland, S., Kaldor, J., Zimet, G., Skinner, R. (2023). Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial. Preventive Medicine, 172. [More Information]
Homaira, N., He, W., McRae, J., Macartney, K., Liu, B. (2023). Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based study. Vaccine, 41(43), 6522-6529. [More Information]
Gidding, H., Stepien, S., Qian, J., Macartney, K., Liu, B. (2023). COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia. Emerging Infectious Diseases, 29(5), 1070-1073. [More Information]
Li-Kim-Moy, J., Phillips, A., Morgan, A., Glover, C., Jayasinghe, S., Hull, B., Dey, A., Beard, F., Hickie, M., Macartney, K. (2023). Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: Descriptive analysis of reports to Australia's spontaneous vaccine pharmacovigilance system, 2016-2020. BMJ Open, 13(1). [More Information]
Liu, B., Stepien, S., Dobbins, T., Gidding, H., Henry, D., Korda, R., Mills, L., Pearson, S., Pratt, N., Vajdic, C., Macartney, K., et al (2023). Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study. The Lancet Regional Health. Western Pacific, 40. [More Information]
Mcrae, J., Macartney, K., McHugh, L., King, C., Beard, F., Blyth, C., Danchin, M., Giles, M., Mohammed, H., Wood, N. (2023). Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016–2021. Medical Journal of Australia, 218(11), 528-541. [More Information]
Homaira, N., Strachan, R., Quinn, H., Beggs, S., Bhuiyan, M., Bowen, A., Fawcett, L., Gilbert, G., Lambert, S., Macartney, K., Snelling, T., et al (2023). Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study. Vaccine, 41(1), 85-91. [More Information]
Middleton, B., Danchin, M., Fathima, P., Bines, J., Macartney, K., Snelling, T. (2023). Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 – 2021. Vaccine, 41(3), 636-648. [More Information]
Gusmão, C., Tanesi, M., Gomes, N., Sheridan, S., Sarmento, N., Oakley, T., David, M., Wapling, J., Alves, L., Amaral, S., Macartney, K., et al (2023). Seroprevalence and prevention of hepatitis B, measles and rubella among healthcare workers in Dili, Timor-Leste. The Lancet Regional Health. Southeast Asia, 13. [More Information]
Patel, C., Dey, A., Wang, H., McIntyre, P., Macartney, K., Beard, F. (2023). Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Final Report. Communicable Diseases Intelligence, 47. [More Information]
Liu, Y., MacNish, M., Dougherty, S., Hagenauer, M., Riley, K., Jadhav, A., Harvey, J., Kaiser, M., Mathew, S., Hodgson, D., Macartney, K., Koirala, A., Khatami, A., et al (2023). Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines. Vaccine, 41(48), 7192-7200. [More Information]
Koirala, A., Winkler, N., Quinn, H., Gardiner, E., Liu, B., Forbes, J., Sharpe, C., van Tussenbroek, T., Wood, N., Macartney, K. (2023). Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study. The Lancet Regional Health. Western Pacific. [More Information]
Arkell, P., Sheridan, S., Martins, N., Tanesi, M., Gomes, N., Amaral, S., Oakley, T., Solano, V., David, M., Draper, A., et al (2023). Vaccine Preventable Disease Seroprevalence in a Nationwide Assessment of Timor-Leste (VASINA-TL): Study protocol for a population-representative cross-sectional serosurvey. BMJ Open, 13(5). [More Information]
Marshall, H., Andraweera, P., Ward, J., Kaldor, J., Andrews, R., Macartney, K., Richmond, P., Krause, V., Koehler, A., Whiley, D., et al (2022). An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol. Vaccines, 10(2), 309. [More Information]
Hull, B., Hendry, A., Dey, A., Brotherton, J., Macartney, K., Beard, F. (2022). Annual immunisation coverage report 2020. Communicable Diseases Intelligence, 46. [More Information]
Tran, C., Valeri, M., Chiu, C., Giles, M., Cheng, A., Macartney, K., Blyth, C., Crawford, N. (2022). ATAGI 2022 Annual Statement on Immunisation. Communicable Diseases Intelligence, 46. [More Information]
Norman, D., Danchin, M., Blyth, C., Palasanthiran, P., Tran, D., Macartney, K., Wadia, U., Moore, H., Seale, H. (2022). Australian hospital paediatricians and nurses’ perspectives and practices for influenza vaccine delivery in children with medical comorbidities. PloS One, 17(12 December). [More Information]
Marshall, K., Quinn, H., Pillsbury, A., Maguire, J., Lucas, R., Dey, A., Beard, F., Macartney, K., McIntyre, P. (2022). Australian vaccine preventable disease epidemiological review series: Pertussis, 2013-2018. Communicable Diseases Intelligence, 46. [More Information]
Blyth, C., Macartney, K. (2022). Calling Future Grandparents - Further Efforts Required to Increase Human Papillomavirus Vaccination Use in Adolescence. Pediatric Infectious Diseases Society, 11(2), 41-42. [More Information]
Williams, P., Koirala, A., Saravanos, G., Lopez, L., Glover, C., Sharma, K., Williams, T., Carey, E., Shaw, N., Dickens, E., Macartney, K., Wood, N., Britton, P., et al (2022). COVID-19 in New South Wales children during 2021: severity and clinical spectrum. Medical Journal of Australia, 217(6), 303-310. [More Information]
Dey, A., Rashid, H., Sharma, K., Phillips, A., Li-Kim-Moy, J., Manocha, R., Macartney, K., Beard, F. (2022). General practitioner knowledge gaps regarding live attenuated zoster vaccination of immunocompromised individuals. Australian Journal of General Practice, 51(7), 529-534. [More Information]
Liu, B., Stepien, S., Pye, V., Law, C., Dalton, C., Durrheim, D., Macartney, K. (2022). High Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.1.529 among 2-Dose Vaccinated Populations in 2 Indoor Entertainment Setting Outbreaks. The Journal of Infectious Diseases, 226(11), 1882-1886. [More Information]
Dalton, L., Meder, K., Beard, F., Dey, A., Hull, B., Macartney, K., McIntyre, P. (2022). How accurately does the Australian Immunisation Register identify children overdue for vaccine doses? A national cross-sectional study. Communicable Diseases Intelligence, 46. [More Information]
Cheng, A., Dwyer, D., Holmes, M., Irving, L., Simpson, G., Senenayake, S., Korman, T., Friedman, N., Cooley, L., Wark, P., et al (2022). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 46. [More Information]
Norman, D., Cheng, A., Macartney, K., Moore, H., Danchin, M., Seale, H., Mcrae, J., Marshall, H., Buttery, J., Francis, J., et al (2022). Influenza hospitalizations in Australian children 2010–2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness. Influenza and Other Respiratory Viruses, 16(2), 316-327. [More Information]
McRae, J., Dey, A., Carlson, S., Sinn, J., McIntyre, P., Beard, F., Macartney, K., Wood, N. (2022). Influenza vaccination among pregnant women in two hospitals in Sydney, NSW: what we can learn from women who decline vaccination. Public Health Research and Practice, 32(2). [More Information]
Carlson, S., Mcrae, J., Wiley, K., Leask, J., Macartney, K. (2022). Knowledge, attitudes and practices regarding influenza vaccination among parents of infants hospitalised for acute respiratory infection in Australia. Public Health Research and Practice, 32(4). [More Information]
Quinn, H., Comeau, J., Marshall, H., Elliott, E., Crawford, N., Blyth, C., Snelling, T., Richmond, P., Francis, J., Macartney, K., McIntyre, P., Wood, N. (2022). Pertussis Disease and Antenatal Vaccine Effectiveness in Australian Children. Pediatric Infectious Disease Journal, 41(3), 180-185. [More Information]
Mcrae, J., Blyth, C., Cheng, A., Quinn, H., Wood, N., Macartney, K. (2022). Preventing severe influenza in Australian infants: Maternal influenza vaccine effectiveness in the PAEDS-FluCAN networks using the test-negative design. Vaccine, 40(19), 2761-2771. [More Information]
Liu, B., Gidding, H., Stepien, S., Cretikos, M., Macartney, K. (2022). Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection. Vaccine, 40(43), 6288-6294. [More Information]
Saravanos, G., Hsu, P., Isaacs, D., Macartney, K., Wood, N., Britton, P. (2022). Respiratory Syncytial Virus-attributable Deaths in a Major Pediatric Hospital in New South Wales, Australia, 1998-2018. Pediatric Infectious Disease Journal, 41(3), 186-191. [More Information]
Mcrae, J., Blyth, C., Cheng, A., Quinn, H., Wood, N., Macartney, K. (2022). Risk factors and disease severity in Australian infants aged under 6 months hospitalised with influenza 2011–2019. Journal of Paediatrics and Child Health, 58(5), 848-855. [More Information]
Machalek, D., Vette, K., Collins, M., Carlin, J., Nicholson, S., Hirani, R., Irving, D., Gosbell, I., Gidding, H., Shilling, H., et al (2022). Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020. PloS One, 17(2024-07-07 00:00:00). [More Information]
Vette, K., Machalek, D., Gidding, H., Nicholson, S., O'Sullivan, M., Carlin, J., Downes, M., Armstrong, L., Beard, F., Dwyer, D., Quinn, H., Macartney, K., et al (2022). Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey. Open Forum Infectious Diseases, 9(3), ofac002. [More Information]
Sheel, M., Wood, N., Macartney, K., Buttery, J., Dinsmore, N., Marshall, H., Elliott, E., Kynaston, A., Richmond, P., Chateau, D., McIntyre, P. (2022). Severity of Rotavirus-Vaccine-Associated Intussusception: Prospective Hospital-Based Surveillance, Australia, 2007-2018. Pediatric Infectious Disease Journal, 41(6), 507-513. [More Information]
Deng, L., Macartney, K., Gill, D., Fathima, P., Wood, N., Gidding, H. (2022). Status epilepticus outcomes among vaccinated and unvaccinated children: A population-based study. Epilepsy and Behavior, 126, 1-9. [More Information]
Patel, C., Dey, A., Wang, H., McIntyre, P., Macartney, K., Beard, F. (2022). Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Final Report. Communicable Diseases Intelligence, 46. [More Information]
Begum, H., Dwyer, D., Holmes, M., Irving, L., Simpson, G., Senenayake, S., Korman, T., Friedman, N., Cooley, L., Wark, P., et al (2022). Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 46. [More Information]
Dey, A., Wang, H., Quinn, H., Pillsbury, A., Hickie, M., Deng, L., Wood, N., Beard, F., Macartney, K. (2022). Surveillance of adverse events following immunisation in Australia annual report, 2020. Communicable Diseases Intelligence, 46. [More Information]
Deng, L., Glover, C., Dymock, M., Pillsbury, A., Marsh, J., Quinn, H., Cashman, P., Snelling, T., Wood, N., Macartney, K. (2022). The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021. Medical Journal of Australia, 217(4), 195-202. [More Information]
Homaira, N., Binks, M., Walker, G., Larter, N., Clark, K., Campbell, M., McHugh, L., Briggs, N., Nyiro, J., Stelzer-Braid, S., Snelling, T., et al (2022). Transplacental transfer of RSV antibody in Australian First Nations infants. Journal of Medical Virology, 94(2), 782-786. [More Information]
Stapelberg, N., Smoll, N., Randall, M., Palipana, D., Bui, B., Macartney, K., Khandaker, G., Wattiaux, A. (2021). A discrete-event, simulated social agent- based network transmission (DESSABNeT) model for communicable diseases: Method and validation using SARS-CoV-2 data in three large Australian cities. PloS One, 16(5 May). [More Information]
Strachan, R., Homaira, N., Beggs, S., Bhuiyan, M., Gilbert, G., Lambert, S., Macartney, K., Marshall, H., Martin, A., McCallum, G., Snelling, T., et al (2021). Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax, 76(5), 487-493. [More Information]
Tran, C., Chiu, C., Cheng, A., Crawford, N., Giles, M., Macartney, K., Blyth, C. (2021). ATAGI 2021 annual statement on immunisation Last updated: 19 September 2021. Communicable Diseases Intelligence, 45. [More Information]
Carlson, S., Quinn, H., Blyth, C., Cheng, A., Clark, J., Francis, J., Marshall, H., Macartney, K., Leask, J. (2021). Barriers to influenza vaccination of children hospitalised for acute respiratory illness: A cross-sectional survey. Journal of Paediatrics and Child Health, 57(3), 409-418. [More Information]
Fielding, J., Sullivan, S., Beard, F., Macartney, K., Williams, J., Dawson, A., Gilbert, G., Massey, P., Crooks, K., Moss, R., et al (2021). Constructing an ethical framework for priority allocation of pandemic vaccines. Vaccine, 39(5), 797-804. [More Information]
Qian, J., Banks, E., Macartney, K., Heywood, A., Lassere, M., Liu, B. (2021). Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort. Mayo Clinic Proceedings, 96(11), 2843-2853. [More Information]
McIntyre, P., Joo, Y., Chiu, C., Flanagan, K., Macartney, K. (2021). COVID-19 vaccines - Are we there yet? Australian Prescriber, 44(1), 19-25. [More Information]
Britton, P., Koirala, A., Wood, N., Macartney, K. (2021). COVID-19, children and schools: overlooked and at risk. Medical Journal of Australia, 214(4), 189-1.89E+03. [More Information]
Phillips, A., Carlson, S., Danchin, M., Beard, F., Macartney, K. (2021). From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years. Vaccine, 39(40), 5968-5981. [More Information]
Hull, B., Hendry, A., Dey, A., McIntyre, P., Macartney, K., Beard, F. (2021). Immunisation Coverage Annual Report 2018. Communicable Diseases Intelligence, 45, 1-38. [More Information]
Hull, B., Hendry, A., Dey, A., Macartney, K., Beard, F. (2021). Immunisation Coverage Annual Report 2019. Communicable Diseases Intelligence, 45, 1-38. [More Information]
Carlson, S., Blyth, C., Beard, F., Hendry, A., Cheng, A., Quinn, H., Leask, J., Macartney, K. (2021). Influenza disease and vaccination in children in Australia. Medical Journal of Australia, 215(2), 64-6.70E+02. [More Information]
Beard, F., Hendry, A., Macartney, K. (2021). Influenza vaccination uptake in Australia in 2020: impact of the COVID-19 pandemic? Communicable Diseases Intelligence, 45. [More Information]
Kerr, J., Macartney, K., Britton, P. (2021). Influenza-associated myositis: a single-centre, 5-year retrospective study. European Journal of Pediatrics, 180(2), 577-584. [More Information]
Koirala, A., Goldfeld, S., Bowen, A., Choong, C., Ryan, K., Wood, N., Winkler, N., Danchin, M., Macartney, K., Russell, F. (2021). Lessons learnt during the COVID-19 pandemic: Why Australian schools should be prioritised to stay open. Journal of Paediatrics and Child Health, 57(9), 1362-1369. [More Information]
Patel, C., Dalton, L., Dey, A., Macartney, K., Beard, F. (2021). Letter: Impact of the COVID-19 pandemic on pharmacist-administered vaccination services. Research in Social and Administrative Pharmacy, 17(1), 2040-2041. [More Information]
Wurzel, D., McMinn, A., Hoq, M., Blyth, C., Burgner, D., Tosif, S., Buttery, J., Carr, J., Clark, J., Cheng, A., Singh-Grewal, D., Wood, N., Macartney, K., Britton, P., et al (2021). Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: A national cohort study. BMJ Open, 11(11), e054510. [More Information]
Qian, J., Macartney, K., Heywood, A., Sheridan, S., Liu, B. (2021). Risk of recurrent herpes zoster in a population-based cohort study of older adults. Journal Of The American Academy Of Dermatology, 85(3), 611-618. [More Information]
Newall, A., Leong, R., Reyes, J., Curns, A., Rudd, J., Tate, J., Macartney, K., Parashar, U. (2021). Rotavirus vaccination likely to be cost saving to society in the United States. Clinical Infectious Diseases, 73(8), 1424-1430. [More Information]
Phillips, A., Glover, C., Leeb, A., Cashman, P., Fathima, P., Crawford, N., Snelling, T., Durrheim, D., Macartney, K. (2021). Safety of live attenuated herpes zoster vaccine in Australian adults 70-79 years of age: An observational study using active surveillance. BMJ Open, 11(3), e043880. [More Information]
Davies, C., Stoney, T., Hutton, H., Parrella, A., Kang, M., Macartney, K., Leask, J., McCaffery, K., Zimet, G., Brotherton, J., Skinner, R., et al (2021). School-based HPV vaccination positively impacts parents’ attitudes toward adolescent vaccination. Vaccine, 39(30), 4190-4198. [More Information]
Gidding, H., Machalek, D., Hendry, A., Quinn, H., Vette, K., Beard, F., Shilling, H., Hirani, R., Gosbell, I., Irving, D., O'Sullivan, M., Dwyer, D., Macartney, K., et al (2021). Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020. Medical Journal of Australia, 214(4), 179-185. [More Information]
Dey, A., Wang, H., Quinn, H., Pillsbury, A., Glover, C., Hickie, M., Wood, N., Beard, F., Macartney, K. (2021). Surveillance of adverse events following immunisation in Australia annual report, 2019. Communicable Diseases Intelligence, 45. [More Information]
Koirala, A., Wood, N., Macartney, K. (2021). Testing for SARS-CoV-2 infection: a key strategy to keeping schools and universities open. The Lancet Child and Adolescent Health, 5(6), 387-389. [More Information]
Hull, B., Hendry, A., Dey, A., Bryant, K., Radkowski, C., Pellissier, S., Macartney, K., Beard, F. (2021). The impact of the COVID-19 pandemic on routine vaccinations in Victoria. Medical Journal of Australia, 215(2), 83-84. [More Information]
Glover, C., Crawford, N., Leeb, A., Wood, N., Macartney, K. (2020). Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. Vaccine, 38(31), 4892-4900. [More Information]
Top, K., Macartney, K., Bettinger, J., Tan, B., Blyth, C., Marshall, H., Vaudry, W., Halperin, S., McIntyre, P. (2020). Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia. Eurosurveillance, 25(25), 1-12. [More Information]
Phillips, A., Hickie, M., Totterdell, J., Brotherton, J., Dey, A., Hill, R., Snelling, T., Macartney, K. (2020). Adverse events following HPV vaccination: 11 years of surveillance in Australia. Vaccine, 38, 6038-6046. [More Information]
Phillips, A., Hickie, M., Totterdell, J., Brotherton, J., Dey, A., Hill, R., Snelling, T., Macartney, K. (2020). Association between rotavirus vaccination and intussusception in Australian children: A record linkage study. Paediatric and Perinatal Epidemiology, 34(5), 6038-6046. [More Information]
Wood, N., Macartney, K., Leask, J., McIntyre, P. (2020). Australia needs a vaccine injury compensation scheme: Upcoming COVID-19 vaccines make its introduction urgent. Australian Journal of General Practice, 49. [More Information]
Rashid, H., Dey, A., Manocha, R., Tashani, M., Macartney, K., Beard, F. (2020). Australia's national zoster vaccination program: Knowledge, attitudes and behaviour of general practitioners. Communicable Diseases Intelligence, 44, 1-10. [More Information]
Patel, C., Beard, F., Hendry, A., Quinn, H., Dey, A., Macartney, K., Hueston, L., Dwyer, D., McIntyre, P. (2020). Australian mumps serosurvey 2012-2013: any cause for concern? Communicable Diseases Intelligence, 44, 1-23. [More Information]
Maguire, J., Beard, F., Méder, K., Dey, A., Macartney, K., McIntyre, P. (2020). Australian vaccine preventable disease epidemiological review series: invasive Haemophilus influenzae type b disease, 2000-2017. Communicable Diseases Intelligence, 44. [More Information]
Britton, P., Dale, R., Blyth, C., Clark, J., Crawford, N., Marshall, H., Elliott, E., Macartney, K., Booy, R., Jones, C. (2020). Causes and Clinical Features of Childhood Encephalitis: A Multicenter, Prospective Cohort Study. Clinical Infectious Diseases, 70(12), 2517-2526. [More Information]
Pillsbury, A., Fathima, P., Quinn, H., Cashman, P., Blyth, C., Leeb, A., Macartney, K. (2020). Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older. JAMA Network Open, 3(5), 1-13. [More Information]
Britton, P., Hu, N., Saravanos, G., Shrapnel, J., Davis, J., Snelling, T., Dalby-Payne, J., Kesson, A., Wood, N., Macartney, K., McCullagh, C., et al (2020). COVID-19 public health measures and respiratory syncytial virus. The Lancet Child and Adolescent Health, 4(11), e42-e43. [More Information]
Deng, L., Wood, N., Macartney, K., Gold, M., Crawford, N., Buttery, J., Richmond, P., Barton, B. (2020). Developmental outcomes following vaccine-proximate febrile seizures in children. Neurology, 95(3), E226-E238. [More Information]
Khatami, A., Burrell, R., McMullan, B., Rawlinson, W., Givney, R., Kok, J., Alexandersen, S., Jones, C., Macartney, K., Britton, P. (2020). Epidemic and Inter-epidemic Burden of Pediatric Human Parechovirus Infection in New South Wales, Australia, 2017-2018. Pediatric Infectious Disease Journal, 39(6), 507-511. [More Information]
Jayasinghe, S., Sheridan, S., Macartney, K. (2020). Herpes zoster vaccination in Australia: What’s available and who benefits? Australian Prescriber, 43(1), 2-6. [More Information]
Beard, F., Hendry, A., Macartney, K. (2020). Influenza vaccination uptake in our most vulnerable groups: how well are we protecting them in 2019? Communicable Diseases Intelligence, 44. [More Information]
Patel, C., Chiu, C., Beard, F., Crawford, N., Macartney, K. (2020). One disease, two vaccines: challenges in prevention of meningococcal disease. Medical Journal of Australia, 212(10), 453-456.e1. [More Information]
McRae, J., Quinn, H., Saravanos, G., Carlson, S., Britton, P., Crawford, N., Wood, N., Marshall, H., Macartney, K. (2020). Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence, 44. [More Information]
Frank, O., De Oliveira Bernardo, C., Gonzalez-Chica, D., Macartney, K., Menzies, R., Stocks, N. (2020). Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Human Vaccines and Immunotherapeutics, 16(4), 965-971. [More Information]
Flanagan, K., Best, E., Crawford, N., Giles, M., Koirala, A., Macartney, K., Russell, F., Teh, B., Wen, S. (2020). Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Frontiers in Immunology, 11, 579250. [More Information]
Totterdell, J., Phillips, A., Glover, C., Chidwick, K., Marsh, J., Snelling, T., Macartney, K. (2020). Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program. Vaccine, 38(23), 3968-3979. [More Information]
Marshall, H., Koehler, A., Wang, B., A'Houre, M., Gold, M., Quinn, H., Crawford, N., Pratt, N., Sullivan, T., Macartney, K. (2020). Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine, 38(37), 5914-5922. [More Information]
Wnukowski-Mtonga, P., Jayasinghe, S., Chiu, C., Macartney, K., Brotherton, J., Donovan, B., Hall, M., Smith, D., Peterson, K., Campbell-Lloyd, S., et al (2020). Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Communicable Diseases Intelligence, 44. [More Information]
Damiano, J., Deng, L., Li, W., Burgess, R., Schneider, A., Crawford, N., Buttery, J., Gold, M., Richmond, P., Macartney, K., Wood, N., et al (2020). SCN1A variants in vaccine-related febrile seizures: a prospective study. Annals of Neurology, 87(2), 281-288. [More Information]
Dey, A., Wang, H., Quinn, H., Pillsbury, A., Glover, C., Hickie, M., Wood, N., Beard, F., Macartney, K. (2020). Surveillance of adverse events following immunisation in Australia: annual report, 2018. Communicable Diseases Intelligence, 44. [More Information]
Blyth, C., Cheng, A., Crawford, N., Clark, J., Buttery, J., Marshall, H., Francis, J., Mcrae, J., Kotsimbos, T., Kelly, P., Macartney, K. (2020). The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018. Vaccine, 38(13), 2779-2787. [More Information]
Li-Kim-Moy, J., Macartney, K. (2020). Time to prioritise influenza vaccination in pregnancy. The Lancet Infectious Diseases, 21(1), 8-10. [More Information]
Macartney, K., Quinn, H., Pillsbury, A., Koirala, A., Deng, L., Winkler, N., Katelaris, A., O'Sullivan, M., Dalton, C., Wood, N. (2020). Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study. The Lancet Child and Adolescent Health, 4(11), 807-816. [More Information]
Sullivan, S., Carlson, S., Cheng, A., Chilver, M., Dwyer, D., Irwin, M., Kok, J., Macartney, K., MacLachlan, J., Minney-Smith, C., et al (2020). Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Eurosurveillance, 25(47), 2001847. [More Information]
Hull, B., Beard, F., Hendry, A., Dey, A., Macartney, K. (2020). “No jab, no pay”: catch-up vaccination activity during its first two years. Medical Journal of Australia, 213(8), 364-369. [More Information]
Hull, B., Hendry, A., Dey, A., Brotherton, J., Macartney, K., Beard, F. (2019). Annual Immunisation Coverage Report 2017. Communicable Diseases Intelligence, 43, 1-49. [More Information]
Carlson, S., Scanlan, C., Marshall, H., Blyth, C., Macartney, K., Leask, J. (2019). Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia. Vaccine, 37(40), 5994-6001. [More Information]
Macdonald-Laurs, E., Koirala, A., Britton, P., Rawlinson, W., Hiew, C., Mcrae, J., Dale, R., Jones, C., Macartney, K., McMullan, B., et al (2019). CSF neopterin, a useful biomarker in children presenting with influenza associated encephalopathy? European Journal of Paediatric Neurology, 23(1), 204-213. [More Information]
Beard, F., Hendry, A., Macartney, K. (2019). Early success with room for improvement: influenza vaccination of young Australian children. Medical Journal of Australia, 210(11), 484-486.e1. [More Information]
Chamings, A., Druce, J., Caly, L., Yoga, Y., Britton, P., Macartney, K., Alexandersen, S. (2019). Evolutionary analysis of human parechovirus type 3 and clinical outcomes of infection during the 2017-18 Australian epidemic. Scientific Reports, 9(1), 1-9. [More Information]
Cheng, A., Holmes, M., Dwyer, D., Senanayake, S., Cooley, L., Irving, L., Simpson, G., Korman, T., Macartney, K., Friedman, N., et al (2019). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 43, 1-17. [More Information]
Cheng, A., Holmes, M., Dwyer, D., Senanayake, S., Cooley, L., Irving, L., Simpson, G., Korman, T., Macartney, K., Friedman, N., et al (2019). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 43, 1-15. [More Information]
Blyth, C., Macartney, K., Mcrae, J., Clark, J., Marshall, H., Buttery, J., Francis, J., Kotsimbos, T., Kelly, P., Cheng, A. (2019). Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration. Clinical Infectious Diseases, 68(6), 940-948. [More Information]
Macartney, K. (2019). Long-term protection against varicella with two-dose combination measles-mumps-rubella-varicella vaccine. The Lancet Infectious Diseases, 19(3), 222-223. [More Information]
McRae, J., Quinn, H., Saravanos, G., McMinn, A., Britton, P., Wood, N., Marshall, H., Macartney, K. (2019). Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence, 43, 1-15.
Deng, L., Gidding, H., Macartney, K., Crawford, N., Buttery, J., Gold, M., Richmond, P., Wood, N. (2019). Postvaccination Febrile Seizure Severity and Outcome. Pediatrics, 143(5), 1-9. [More Information]
Saravanos, G., Sheel, M., Homaira, N., Dey, A., Brown, E., Wang, H., Macartney, K., Wood, N. (2019). Respiratory syncytial virus-associated hospitalisations in Australia, 2006-2015. Medical Journal of Australia, 210(10), 447-453. [More Information]
Qian, J., Heywood, A., Karki, S., Banks, E., Macartney, K., Chantrill, L., Liu, B. (2019). Risk of Herpes Zoster Prior to and Following Cancer Diagnosis and Treatment: A Population-Based Prospective Cohort Study. The Journal of Infectious Diseases, 220(1), 3-11. [More Information]
Maguire, J., Glasgow, K., Glass, K., Roczo-Farkas, S., Bines, J., Sheppeard, V., Macartney, K., Quinn, H. (2019). Rotavirus Epidemiology and Monovalent Rotavirus Vaccine Effectiveness in Australia: 2010-2017. Pediatrics, 144(44), 1-10. [More Information]
Marshall, H., Clarke, M., Heath, C., Quinn, H., Richmond, P., Crawford, N., Elliott, E., Toi, C., Kynaston, A., Booy, R., Macartney, K. (2019). Severe and complicated varicella and associated genotypes 10 years after introduction of a one-dose varicella vaccine program. The Journal of Infectious Diseases, 219(3), 391-399. [More Information]
Dey, A., Wang, H., Beard, F., Macartney, K., McIntyre, P. (2019). Summary of national surveillance data on vaccine preventable diseases in Australia, 2012-2015. Communicable Diseases Intelligence, 43, 1-99. [More Information]
Dey, A., Wang, H., Quinn, H., Hiam, R., Wood, N., Beard, F., Macartney, K. (2019). Surveillance of adverse events following immunisation in Australia annual report, 2017. Communicable Diseases Intelligence, 43, 1-30. [More Information]
Giles, M., Krishnaswamy, S., Macartney, K., Cheng, A. (2019). The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Human Vaccines and Immunotherapeutics, 15(3), 687-699. [More Information]
Ioannides, S., Beard, F., Larter, N., Clark, K., Wang, H., Hendry, A., Hull, B., Dey, A., Chiu, C., Brotherton, J., Jayasinghe, S., Macartney, K., McIntyre, P. (2019). Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011-2015. Communicable Diseases Intelligence, 43, 1-109. [More Information]
Quinn, H., Gidding, H., Marshall, H., Booy, R., Elliott, E., Richmond, P., Crawford, N., McIntyre, P., Macartney, K. (2019). Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. Journal of Infection, 78(3), 220-225. [More Information]
Pillsbury, A., Glover, C., Jacoby, P., Quinn, H., Fathima, P., Cashman, P., Leeb, A., Blyth, C., Gold, M., Snelling, T., Macartney, K. (2018). Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia. BMJ Open, 8(10), 1-11. [More Information]
Edirisuriya, C., Beard, F., Hendry, A., Dey, A., Gidding, H., Hueston, L., Dwyer, D., Wood, J., Macartney, K., McIntyre, P. (2018). Australian rubella serosurvey 2012-2013: On track for elimination? Vaccine, 36(20), 2794-2798. [More Information]
Sheel, M., Beard, F., Quinn, H., Dey, A., Kirk, M., Koehler, A., Markey, P., McIntyre, P., Macartney, K. (2018). Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015. Communicable Diseases Intelligence, 42, 1-27.
Macartney, K., Phillips, A., Patel, C., Pillsbury, A., Brotherton, J. (2018). Authors' reply: Safety of Human Papillomavirus Vaccines. Drug Safety, 41(5), 541-543. [More Information]
Li-Kim-Moy, J., Wood, N., Jones, C., Macartney, K., Booy, R. (2018). Impact of Fever and Antipyretic Use on Influenza Vaccine Immune Reponses in Children. Pediatric Infectious Disease Journal, 37(10), 971-975. [More Information]
Alexander, K., Tong, P., Macartney, K., Beresford, R., Sheppeard, V., Gupta, M. (2018). Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection. Vaccine, 36(27), 3890-3893. [More Information]
Sheridan, S., Patel, C., Macartney, K., Cheng, A. (2018). New enhanced influenza vaccines for older Australians: what promise do they hold? Medical Journal of Australia, 209(3), 110-112.e1. [More Information]
Phillips, A., Patel, C., Pillsbury, A., Brotherton, J., Macartney, K. (2018). Safety of Human Papillomavirus Vaccines: An Updated Review. Drug Safety, 41(4), 329-346. [More Information]
Macartney, K., Gershon, A. (2018). Shingles vaccine after auto-HSCT decreases risk. The Lancet, 391(10135), 2082-2084. [More Information]
Dey, A., Wang, H., Quinn, H., Cook, J., Macartney, K. (2018). Surveillance of adverse events following immunisation in Australia annual report, 2016. Communicable Diseases Intelligence, 42(1), 11-8.
Patel, C., Brotherton, J., Pillsbury, A., Jayasinghe, S., Donovan, B., Macartney, K., Marshall, H. (2018). The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Eurosurveillance, 23(41), 30-40. [More Information]
Phillips, A., Beard, F., Macartney, K., Chan, J., Gilmour, R., Saravanos, G., McIntyre, P. (2018). Vaccine-preventable child deaths in New South Wales from 2005 to 2014: How much is preventable? Journal of Paediatrics and Child Health, 54(4), 356-364. [More Information]
Pillsbury, A., Quinn, H., Cashman, P., Leeb, A., Macartney, K. (2017). Active SMS-based influenza vaccine safety surveillance in Australian children. Vaccine, 35(51), 7101-7106. [More Information]
Reyes, J., Wood, J., Beutels, P., Macartney, K., McIntyre, P., Menzies, R., Mealing, N., Newall, A. (2017). Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine, 35(2), 345-352. [More Information]
Khatami, A., Khan, F., Macartney, K. (2017). Enteric Fever in Children in Western Sydney, Australia, 2003-2015. Pediatric Infectious Disease Journal, 36(12), 1124-1128. [More Information]
Khandaker, G., Beard, F., Dey, A., Coulter, C., Hendry, A., Macartney, K. (2017). Evaluation of bacille Calmette-Guerin immunisation programs in Australia. Communicable Diseases Intelligence, 41(1), E33-E48.
Macartney, K., Gidding, H., Trinh, L., Wang, H., Dey, A., Hull, B., Orr, K., McRae, J., Richmond, P., Gold, M., McIntyre, P., Wood, N., et al (2017). Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia. JAMA Pediatrics, 171(10), 992-998. [More Information]
Deng, L., Macdougall, R., Macartney, K. (2017). Immunisation: It's not just for kids. Medicine Today, 18(6), 25-33.
Cheng, A., Holmes, M., Dwyer, D., Irving, L., Korman, T., Senenayake, S., Macartney, K., Blyth, C., Brown, S., Waterer, G., et al (2017). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2016: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence Quarterly Report, 41(4), E337-E347.
Li-Kim-Moy, J., Yin, K., Blyth, C., Kesson, A., Booy, R., Cheng, A., Macartney, K. (2017). Influenza hospitalizations in Australian children. Epidemiology and Infection, 145(7), 1451-1460. [More Information]
Britton, P., Dale, R., Blyth, C., Macartney, K., Crawford, N., Marshall, H., Clark, J., Elliott, E., Webster, R., Cheng, A., Booy, R., Jones, C. (2017). Influenza-associated Encephalitis/Encephalopathy Identified by the Australian Childhood Encephalitis Study 2013-2015. Pediatric Infectious Disease Journal, 36(11), 1021-1026. [More Information]
Trinh, L., Macartney, K., McIntyre, P., Chiu, C., Dey, A., Menzies, R. (2017). Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic General Practice data. Vaccine, 35(11), 1524-1529. [More Information]
McRae, J., Quinn, H., Macartney, K. (2017). Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2015: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence, 41(3), E280-E288.
Cashman, P., Macartney, K., Khandaker, G., King, C., Gold, M., Durrheim, D. (2017). Participant-centred active surveillance of adverse events following immunisation: A narrative review. International Health, 9(3), 164-176. [More Information]
Sheel, M., Beard, F., Dey, A., Macartney, K., McIntyre, P. (2017). Rates of hospitalisation for herpes zoster may warrant vaccinating indigenous Australians under 70. Medical Journal of Australia, 207(9), 395-396. [More Information]
Cheng, A., Macartney, K., Waterer, G., Kotsimbos, T., Kelly, P., Blyth, C. (2017). Repeated vaccination does not appear to impact on influenza vaccine effectiveness against hospitalisation with confirmed influenza. Clinical Infectious Diseases, 64(11), 1564-1572. [More Information]
Cheng, A., Macartney, K., Waterer, G., Kotsimbos, T., Kelly, P., Blyth, C. (2017). Reply to Skowronski and Chambers. Clinical Infectious Diseases, 65(2), 355. [More Information]
Patel, C., Macartney, K. (2017). Supporting the call for a gender-neutral human papillomavirus vaccination in Canada. CMAJ, 189(3), E118-E118. [More Information]
Dey, A., Wang, H., Quinn, H., Cook, J., Macartney, K. (2017). Surveillance of adverse events following immunisation in Australia, 2015. Communicable Diseases Intelligence, 41(3), E264-E278.
Yin, K., Heywood, A., Georgousakis, M., King, C., Chiu, C., Isaacs, D., Macartney, K. (2017). Systematic review and meta-analysis of indirect protection afforded by vaccinating children against seasonal influenza: Implications for policy. Clinical Infectious Diseases, 65(5), 719-728. [More Information]
Britton, P., Blyth, C., Macartney, K., Dale, R., Li-Kim-Moy, J., Khandaker, G., Crawford, N., Marshall, H., Clark, J., Elliott, E., Booy, R., Jones, C., et al (2017). The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance from Australia 2013-2015. Clinical Infectious Diseases, 65(4), 653-660. [More Information]
Hendry, A., Dey, A., Beard, F., Khandaker, G., Hill, R., Macartney, K. (2016). Adverse events following immunisation with bacille Calmette-Guerin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine. Communicable Diseases Intelligence Quarterly Report, 40(4), E470-E474.
Li-Kim-Moy, J., Yin, K., Patel, C., Beard, F., Chiu, C., Macartney, K., McIntyre, P. (2016). Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015. Communicable Diseases Intelligence Quarterly Report, 40(4), E482-E495.
DeSilva, M., Munoz, F., Mcmillan, M., Kawai, A., Marshall, H., Macartney, K., Joshi, J., Oneko, M., Rose, A., Dolk, H., et al (2016). Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 34(49), 6015-6026. [More Information]
Wattiaux, A., Yin, K., Beard, F., Wesselingh, S., Cowie, B., Ward, J., Macartney, K. (2016). Hepatitis B immunization for indigenous adults, Australia. Bulletin of the World Health Organization, 94(11), 826-834A. [More Information]
Cheng, A., Holmes, M., Dwyer, D., Irving, L., Korman, T., Senenayake, S., Macartney, K., Blyth, C., Brown, S., Waterer, G., et al (2016). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2015: the Influenza Complications Alert Network. Communicable Diseases Intelligence Quarterly Report, 40(4), E521-E526.
Blyth, C., Macartney, K., Hewagama, S., Senenayake, S., Friedman, N., Simpson, G., Upham, J., Kotsimbos, T., Kelly, P., Cheng, A. (2016). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: The influenza complications alert network (FluCAN). Eurosurveillance, 21(30), 1-9. [More Information]
Comeau, J., Chan, J., Macartney, K. (2016). New Vaccines on the Horizon. Current Pediatrics Reports, 4(3), 74-83. [More Information]
Zurynski, Y., McRae, J., Quinn, H., Wood, N., Macartney, K. (2016). Paediatric Active Enhanced Disease Surveillance inaugural annual report, 2014. Communicable Diseases Intelligence Quarterly Report, 40(3), E391-E400.
Britton, P., Dale, R., Nissen, M., Crawford, N., Elliott, E., Macartney, K., Khandaker, G., Booy, R., Jones, C. (2016). Parechovirus Encephalitis and Neurodevelopmental Outcomes. Pediatrics, 137(2), 1-11. [More Information]
Britton, P., Dale, R., Elliott, E., Macartney, K., Festa, M., Booy, R., Jones, C. (2016). Pilot surveillance for childhood encephalitis in Australia using the Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Epidemiology and Infection, 144(10), 2117-2127. [More Information]
Dey, A., Wang, H., Quinn, H., Hill, R., Macartney, K. (2016). Surveillance of adverse events following immunisation in Australia annual Report, 2014. Communicable Diseases Intelligence, 40(3), E377-E390.
Li-Kim-Moy, J., Dastouri, F., Rashid, H., Khandaker, G., Kesson, A., McCaskill, M., Wood, N., Jones, C., Zurynski, Y., Macartney, K., Elliott, E., Booy, R. (2016). Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department. Journal of Paediatrics and Child Health, 52(4), 422-429. [More Information]
Marshall, H., McMillan, M., Andrews, R., Macartney, K., Edwards, K. (2016). Vaccines in pregnancy: The dual benefit for pregnant women and infants. Human Vaccines and Immunotherapeutics, 12(4), 848-856. [More Information]
Britton, P., Macartney, K., Arbuckle, S., Little, D., Kesson, A. (2015). A Rare Case of Q Fever Osteomyelitis in a Child From Regional Australia. Pediatric Infectious Diseases Society, 4(3), 28-31. [More Information]
Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., Gold, M., Kynaston, J., Blyth, C., Zurynski, Y., Elliott, E., Booy, R., McIntyre, P., Wood, N., et al (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417. [More Information]
Davey, H., Muscatello, D., Wood, J., Snelling, T., Ferson, M., Macartney, K. (2015). Impact of high coverage of monovalent human rotavirus vaccine on Emergency Department presentations for rotavirus gastroenteritis. Vaccine, 33(14), 1726-1730. [More Information]
Cheng, A., Holmes, M., Senenayake, S., Dwyer, D., Hewagama, S., Korman, T., Irving, L., Brown, S., Waterer, G., Hunter, C., Macartney, K., et al (2015). Influenza epidemiology in adults admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 39(3), E355-E360.
Cheng, A., Kotsimbos, T., Kelly, P., Wark, P., Hunter, C., Hewagama, S., Friedman, D., Korman, T., Simpson, G., Dwyer, D., Macartney, K., et al (2015). Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014. Vaccine, 33(51), 7352-7356. [More Information]
Pillsbury, A., Cashman, P., Leeb, A., Regan, A., Westphal, D., Snelling, T., Blyth, C., Crawford, N., Wood, N., Macartney, K. (2015). Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015. Eurosurveillance, 20(43), 6-10. [More Information]
Mahajan, D., Dey, A., Cook, J., Harvey, B., Menzies, R., Macartney, K. (2015). Surveillance of adverse events following immunisation in Australia annual report, 2013. Communicable Diseases Intelligence Quarterly Report, 39(3), e369-e386.
Li-Kim-Moy, J., Yin, K., Rashid, H., Khandaker, G., King, C., Wood, N., Macartney, K., Jones, C., Booy, R. (2015). Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children. Eurosurveillance, 20(24), 1-20. [More Information]
Blyth, C., Cheng, A., Finucane, C., Jacoby, P., Effler, P., Smith, D., Kelly, H., Macartney, K., Richmond, P. (2015). The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia. Vaccine, 33(51), 7239-7244. [More Information]
Quinn, H., Snelling, T., Macartney, K., McIntyre, P. (2014). Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics, 133(3), e513-e519. [More Information]
Beard, F., Macartney, K. (2014). Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG? Medical Journal of Australia, 200(3), 149-149. [More Information]
Quinn, H., Wood, N., Cannings, K., Dey, A., Wang, H., Menzies, R., Moberley, S., Reid, S., McIntyre, P., Macartney, K. (2014). Intussusception after monovalent human rotavirus vaccine in Australia: Severity and comparison of using healthcare database records versus case confirmation to assess risk. Pediatric Infectious Disease Journal, 33(9), 959-965. [More Information]
Mahajan, D., Dey, A., Cook, J., Harvey, B., Menzies, R., Macartney, K. (2014). Surveillance of adverse events following immunisation in Australia, 2012. Communicable Diseases Intelligence Quarterly Report, 38(3), E232-E246.
Wood, N., Blyth, C., Willis, G., Richmond, P., Gold, M., Buttery, J., Crawford, N., Crampton, M., Yin, K., Chow, M., Macartney, K. (2014). The safety of seasonal influenza vaccines in Australian children in 2013. Medical Journal of Australia, 201(10), 596-600. [More Information]
Macartney, K., Heywood, A., McIntyre, P. (2014). Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews, 6, 1-45. [More Information]
Heywood, A., Wang, H., Macartney, K., McIntyre, P. (2014). Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bulletin of the World Health Organization, 92(8), 593-604. [More Information]
Smith, B., Hazelton, B., Heywood, A., Snelling, T., Peacock, K., Macartney, K. (2013). Disseminated tuberculosis and tuberculous meningitis in Australian-born children; case reports and review of current epidemiology and management. Journal of Paediatrics and Child Health, 49(3), e246-e250. [More Information]
Jayasinghe, S., Macartney, K. (2013). Estimating rotavirus gastroenteritis hospitalisations by using hospital episode statistics before and after the introduction of rotavirus vaccine in Australia. Vaccine, 31(6), 967-972. [More Information]
Ward, K., Dey, A., Hull, B., Quinn, H., Macartney, K., Menzies, R. (2013). Evaluation of Australia's varicella vaccination program for children and adolescents. Vaccine, 31(10), 1413-1419. [More Information]
Hull, B., Menzies, R., Macartney, K., McIntyre, P. (2013). Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: The Australian experience. Vaccine, 31(15), 1964-1969. [More Information]
Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., Macartney, K., et al (2013). International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. [More Information]
Carlin, J., Macartney, K., Lee, K., Quinn, H., Buttery, J., Lopert, R., Bines, J., McIntyre, P. (2013). Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clinical Infectious Diseases, 57(10), 1427-1434. [More Information]
Cashmore, A., Muscatello, D., Merrifield, A., Spokes, P., Macartney, K., Jalaludin, B. (2013). Relationship between the population incidence of pertussis in children in New South Wales, Australia and emergency department visits with cough: A time series analysis. BMC Medical Informatics and Decision Making, 13(1), 1-11. [More Information]
Macartney, K., Chiu, C., Georgousakis, M., Brotherton, J. (2013). Safety of human papillomavirus vaccines: a review. Drug Safety, 36(6), 393-412. [More Information]
Wiley, K., Zuo, Y., Macartney, K., McIntyre, P. (2013). Sources of pertussis infection in young infants: A review of key evidence informing targeting of the cocoon strategy. Vaccine, 31(4), 618-625. [More Information]
Mahajan, D., Cook, J., Dey, A., Macartney, K., Menzies, R. (2013). Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012. Communicable Diseases Intelligence Quarterly Report, 37(2), e130-e135. [More Information]
Mahajan, D., Cook, J., Dey, A., Macartney, K., Menzies, R. (2012). Annual report: surveillance of adverse events following immunisation in Australia, 2011. Communicable Diseases Intelligence Quarterly Report, 36(4), E315-E332. [More Information]
Dey, A., Wang, H., Menzies, R., Macartney, K. (2012). Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Medical Journal of Australia, 197(8), 453-457. [More Information]
Khandaker, G., Zurynski, Y., Buttery, J., Marshall, H., Richmond, P., Dale, R., Royle, J., Gold, M., Snelling, T., Whitehead, B., Jones, C., Heron, L., Macartney, K., Elliott, E., Booy, R., et al (2012). Neurologic complications of influenza A(H1N1)pdm09: Surveillance in 6 pediatric hospitals. Neurology, 79(14), 1474-1481. [More Information]
Georgousakis, M., Jayasinghe, S., Brotherton, J., Gilroy, N., Chiu, C., Macartney, K. (2012). Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study. The Lancet Infectious Diseases, 12(8), 627-634. [More Information]
Mahajan, D., Cook, J., McIntyre, P., Macartney, K., Menzies, R. (2012). Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011. Communicable Diseases Intelligence Quarterly Report, 36(1), 114-119. [More Information]
Mahajan, D., Cook, J., McIntyre, P., Macartney, K., Menzies, R. (2011). Annual report: surveillance of adverse events following immunisation in Australia, 2010. Communicable Diseases Intelligence Quarterly Report, 35(4), 263-280. [More Information]
Macartney, K., Porwal, M., Dalton, D., Cripps, T., Maldigri, T., Isaacs, D., Kesson, A. (2011). Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. Journal of Paediatrics and Child Health, 47(5), 266-270. [More Information]
Georgousakis, M., Jelfs, J., Macartney, K. (2011). Immunisation for life: Don't forget adults. Medicine Today, 12(4), 29-37.
Macartney, K., Durrheim, D. (2011). NSW immunisation performance: continuing progress but no room for complacency. NSW Public Health Bulletin, 22(9-10), 169-170. [More Information]
Mahajan, D., Menzies, R., Cook, J., Macartney, K., McIntyre, P. (2011). Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010. Communicable Diseases Intelligence Quarterly Report, 35(1), 21-28. [More Information]
Macartney, K. (2010). Heads Up: Monovalent polio vaccines are better. Journal of Paediatrics and Child Health, 46(5), 275.
Macartney, K. (2010). Pertussis vaccination. Medicine Today, 11, 63-64.
Isaacs, D., Macartney, K., McIntyre, P. (2010). Rapid Response: Benefits and risks of childhood influenza vaccination. BMJ, , 1.
Webster, R., Hazelton, B., Suleiman, J., Macartney, K., Kesson, A., Dale, R. (2010). Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports. Neurology, 74(13), 1077-1078. [More Information]
Chiu, C., Dey, A., Wang, H., Menzies, R., Deeks, S., Mahajan, D., Macartney, K., Jardine, A., Quinn, H., Jelfs, J., Booy, R., Lawrence, G., Wood, N., McIntyre, P., et al (2010). Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence Quarterly Report, 34, S1-167. [More Information]
Wood, J., Gidding, H., Heywood, A., Macartney, K., McIntyre, P., MacIntyre, C. (2009). Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Vaccine, 27(2), 313-318. [More Information]
Macartney, K., Burgess, M. (2009). Rapid impact of rotavirus vaccination in the United States: implications for Australia. Medical Journal of Australia, 191(3), 131-132. [More Information]
Macartney, K. (2009). What's new in childhood immunisation? Medicine Today, 10, 24-30.
Wood, J., MacIntyre, R., Macartney, K. (2008). Assessing varicella vaccine efficacy. Pediatric Infectious Disease Journal, 27(2), 190; author reply 190-1. [More Information]
Leask, J., Quinn, H., Macartney, K., Trent, M., Massey, P., Carr, C., Turahui, J. (2008). Immunisation attitudes, knowledge and practices of health professionals in regional NSW. Australian and New Zealand Journal of Public Health, 32(3), 224-229. [More Information]
Leask, J., Macartney, K. (2008). Parental decisions about vaccination: Collective values are important. Journal of Paediatrics and Child Health, 44(10), 534-535. [More Information]
Inglis, E., Kesson, A., Newell, A., Macartney, K., MacIntyre, C. (2008). The burden of rotavirus gastroenteritis in children presenting to a paediatric hospital. Epidemiology and Infection, 137(7), 943-949. [More Information]
Macartney, K., McIntyre, P. (2008). Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews, 2008 (3), CD001833-1-CD001833-27. [More Information]
Macartney, K., Burgess, M. (2008). Varicella vaccination in Australia and New Zealand. The Journal of Infectious Diseases, 197, S191-5. [More Information]
Macartney, K., MacIntyre, C., McIntyre, P. (2007). Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006. Communicable Diseases Intelligence Quarterly Report, 31(3), 303-310. [More Information]
Newall, A., Beutels, P., Macartney, K., Wood, J., MacIntyre, C. (2007). The cost-effectiveness of rotavirus vaccination in Australia. Vaccine, 25, 8851-8860. [More Information]
Brotherton, J., Wang, H., Schaffer, A., Quinn, H., Menzies, R., Hull, B., Lawrence, C., Wood, J., Wood, N., Rosewell, A., Newall, A., Macartney, K., Gidding, H., McIntyre, P., Booy, R., et al (2007). Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence Quarterly Report, 31(Suppl June 2007), 1-152. [More Information]
Newall, A., MacIntyre, C., Wang, H., Hull, B., Macartney, K. (2006). Burden of severe rotavirus disease in Australia. Journal of Paediatrics and Child Health, 42(9), 521-527. [More Information]
Macartney, K., McIntyre, P. (2005). Universal varicella vaccination. Comment. Medical Journal of Australia, 183(5), 278-9. [More Information]
Macartney, K., Beutels, P., McIntyre, P., Burgess, M. (2005). Varicella vaccination in Australia. Journal of Paediatrics and Child Health, 41(11), 544-552. [More Information]

show 225 more

By Year

Expand all

2025

Jayasinghe, S., Williams, P., Macartney, K., Crawford, N., Blyth, C. (2025). Assessing the impact of pneumococcal conjugate vaccine immunisation schedule change from 3+0 to 2+1 in Australian children: A retrospective observational study (In Press). Clinical Infectious Diseases, 80(1), 207-214. [More Information]
Nguyen, T., Dawes, L., Huang, Y., Tay, E., Dymock, M., O’Moore, M., King, C., Macartney, K., Wood, N., Deng, L. (2025). Short term safety profile of respiratory syncytial virus vaccine in adults aged ≥ 60 years in Australia. The Lancet Regional Health. Western Pacific, 56(101506), 1-3. [More Information]

2024

Sonneveld, N., Jackson, J., Dey, A., Lambert, S., Clark, K., Cowie, B., Macartney, K., Beard, F. (2024). Australian vaccine preventable disease epidemiological review series: Hepatitis B, 2000-2019. Communicable Diseases Intelligence, 48. [More Information]
Faksova, K., Grange, Z., Escolano, S., Sepulveda, G., Shetty, A., Pillsbury, A., Sullivan, C., Naveed, Z., Janjua, N., Giglio, N., Gidding, H., Macartney, K., et al (2024). COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine, 42(9), 2200-2211. [More Information]
Koirala, A., Winkler, N., Sharpe, C., van Tussenbroek, T., Wood, P., Macartney, K., Quinn, H. (2024). Real-world utilisation of SARS-CoV-2 rapid antigen testing to enable face-to-face learning in Australian schools, an ecological study. Australian and New Zealand Journal of Public Health, 48(3), 100159. [More Information]
Imai, C., Jayasinghe, S., McRae, J., Li-Kim-Moy, J., Chiu, C., Macartney, K., Burns, P., Cooper, K., Cheng, A., Gibney, K., Jones, C., et al (2024). Surveillance of adverse events following immunisation in Australia annual report, 2021. Communicable Diseases Intelligence, 48. [More Information]
Glover, C., Deng, L., Larter, C., Brogan, C., Richardson, O., Huang, Y., Kay, E., Macartney, K., Wood, N. (2024). Surveillance of adverse events following immunisation in Australia annual report, 2021. Communicable Diseases Intelligence, 48. [More Information]
Glover, C., Deng, L., Larter, C., Brogan, C., Richardson, O., Huang, Y., Kay, E., Macartney, K., Wood, N. (2024). Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021. Communicable Diseases Intelligence, 48. [More Information]
Baldwin, Z., Hope, K., Glasgow, K., Hueston, L., Roberts-Witteveen, A., Stanley, P., Sheel, M., Winkler, N., Koirala, A., Macartney, K., et al (2024). The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross-sectional serosurvey. Medical Journal of Australia, 220(11), 561-565. [More Information]

show 4 more

2023

Ramsay, J., Jones, M., Vande More, A., Hunt, S., Williams, P., Messer, M., Wood, N., Macartney, K., Lee, F., Britton, W., Snelling, T., Caterson, I. (2023). A single blinded, phase IV, adaptive randomised control trial to evaluate the safety of coadministration of seasonal influenza and COVID-19 vaccines (The FluVID study). Vaccine, 41(48), 7250-7258. [More Information]
Hull, B., Hendry, A., Dey, A., Brotherton, J., Macartney, K., Beard, F. (2023). Annual immunisation coverage report 2021. Communicable Diseases Intelligence, 47. [More Information]
Pillsbury, A., Phillips, A., Deng, L., Quinn, H., Macartney, K., Gidding, H. (2023). Background incidence rates of selected adverse events of special interest (AESI) to monitor the safety of COVID-19 vaccines. Vaccine, 41(22), 3422-3428. [More Information]
Liu, B., Stepien, S., Qian, J., Gidding, H., Nicolopoulos, K., Amin, J., Cheng, A., Macartney, K. (2023). Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection. Vaccine, 41(38), 5587-5591. [More Information]
Davies, C., Marshall, H., Brotherton, J., McCaffery, K., Kang, M., Macartney, K., Garland, S., Kaldor, J., Zimet, G., Skinner, R. (2023). Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial. Preventive Medicine, 172. [More Information]
Homaira, N., He, W., McRae, J., Macartney, K., Liu, B. (2023). Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based study. Vaccine, 41(43), 6522-6529. [More Information]
Gidding, H., Stepien, S., Qian, J., Macartney, K., Liu, B. (2023). COVID-19 Vaccine Uptake by Infection Status in New South Wales, Australia. Emerging Infectious Diseases, 29(5), 1070-1073. [More Information]
Li-Kim-Moy, J., Phillips, A., Morgan, A., Glover, C., Jayasinghe, S., Hull, B., Dey, A., Beard, F., Hickie, M., Macartney, K. (2023). Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: Descriptive analysis of reports to Australia's spontaneous vaccine pharmacovigilance system, 2016-2020. BMJ Open, 13(1). [More Information]
Liu, B., Stepien, S., Dobbins, T., Gidding, H., Henry, D., Korda, R., Mills, L., Pearson, S., Pratt, N., Vajdic, C., Macartney, K., et al (2023). Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study. The Lancet Regional Health. Western Pacific, 40. [More Information]
Mcrae, J., Macartney, K., McHugh, L., King, C., Beard, F., Blyth, C., Danchin, M., Giles, M., Mohammed, H., Wood, N. (2023). Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016–2021. Medical Journal of Australia, 218(11), 528-541. [More Information]
Homaira, N., Strachan, R., Quinn, H., Beggs, S., Bhuiyan, M., Bowen, A., Fawcett, L., Gilbert, G., Lambert, S., Macartney, K., Snelling, T., et al (2023). Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study. Vaccine, 41(1), 85-91. [More Information]
Middleton, B., Danchin, M., Fathima, P., Bines, J., Macartney, K., Snelling, T. (2023). Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006 – 2021. Vaccine, 41(3), 636-648. [More Information]
Gusmão, C., Tanesi, M., Gomes, N., Sheridan, S., Sarmento, N., Oakley, T., David, M., Wapling, J., Alves, L., Amaral, S., Macartney, K., et al (2023). Seroprevalence and prevention of hepatitis B, measles and rubella among healthcare workers in Dili, Timor-Leste. The Lancet Regional Health. Southeast Asia, 13. [More Information]
Patel, C., Dey, A., Wang, H., McIntyre, P., Macartney, K., Beard, F. (2023). Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Final Report. Communicable Diseases Intelligence, 47. [More Information]
Liu, Y., MacNish, M., Dougherty, S., Hagenauer, M., Riley, K., Jadhav, A., Harvey, J., Kaiser, M., Mathew, S., Hodgson, D., Macartney, K., Koirala, A., Khatami, A., et al (2023). Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines. Vaccine, 41(48), 7192-7200. [More Information]
Koirala, A., Winkler, N., Quinn, H., Gardiner, E., Liu, B., Forbes, J., Sharpe, C., van Tussenbroek, T., Wood, N., Macartney, K. (2023). Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study. The Lancet Regional Health. Western Pacific. [More Information]
Arkell, P., Sheridan, S., Martins, N., Tanesi, M., Gomes, N., Amaral, S., Oakley, T., Solano, V., David, M., Draper, A., et al (2023). Vaccine Preventable Disease Seroprevalence in a Nationwide Assessment of Timor-Leste (VASINA-TL): Study protocol for a population-representative cross-sectional serosurvey. BMJ Open, 13(5). [More Information]

show 14 more

2022

Marshall, H., Andraweera, P., Ward, J., Kaldor, J., Andrews, R., Macartney, K., Richmond, P., Krause, V., Koehler, A., Whiley, D., et al (2022). An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol. Vaccines, 10(2), 309. [More Information]
Hull, B., Hendry, A., Dey, A., Brotherton, J., Macartney, K., Beard, F. (2022). Annual immunisation coverage report 2020. Communicable Diseases Intelligence, 46. [More Information]
Tran, C., Valeri, M., Chiu, C., Giles, M., Cheng, A., Macartney, K., Blyth, C., Crawford, N. (2022). ATAGI 2022 Annual Statement on Immunisation. Communicable Diseases Intelligence, 46. [More Information]
Norman, D., Danchin, M., Blyth, C., Palasanthiran, P., Tran, D., Macartney, K., Wadia, U., Moore, H., Seale, H. (2022). Australian hospital paediatricians and nurses’ perspectives and practices for influenza vaccine delivery in children with medical comorbidities. PloS One, 17(12 December). [More Information]
Marshall, K., Quinn, H., Pillsbury, A., Maguire, J., Lucas, R., Dey, A., Beard, F., Macartney, K., McIntyre, P. (2022). Australian vaccine preventable disease epidemiological review series: Pertussis, 2013-2018. Communicable Diseases Intelligence, 46. [More Information]
Blyth, C., Macartney, K. (2022). Calling Future Grandparents - Further Efforts Required to Increase Human Papillomavirus Vaccination Use in Adolescence. Pediatric Infectious Diseases Society, 11(2), 41-42. [More Information]
Williams, P., Koirala, A., Saravanos, G., Lopez, L., Glover, C., Sharma, K., Williams, T., Carey, E., Shaw, N., Dickens, E., Macartney, K., Wood, N., Britton, P., et al (2022). COVID-19 in New South Wales children during 2021: severity and clinical spectrum. Medical Journal of Australia, 217(6), 303-310. [More Information]
Dey, A., Rashid, H., Sharma, K., Phillips, A., Li-Kim-Moy, J., Manocha, R., Macartney, K., Beard, F. (2022). General practitioner knowledge gaps regarding live attenuated zoster vaccination of immunocompromised individuals. Australian Journal of General Practice, 51(7), 529-534. [More Information]
Liu, B., Stepien, S., Pye, V., Law, C., Dalton, C., Durrheim, D., Macartney, K. (2022). High Attack Rate of Severe Acute Respiratory Syndrome Coronavirus 2 B.1.1.529 among 2-Dose Vaccinated Populations in 2 Indoor Entertainment Setting Outbreaks. The Journal of Infectious Diseases, 226(11), 1882-1886. [More Information]
Dalton, L., Meder, K., Beard, F., Dey, A., Hull, B., Macartney, K., McIntyre, P. (2022). How accurately does the Australian Immunisation Register identify children overdue for vaccine doses? A national cross-sectional study. Communicable Diseases Intelligence, 46. [More Information]
Cheng, A., Dwyer, D., Holmes, M., Irving, L., Simpson, G., Senenayake, S., Korman, T., Friedman, N., Cooley, L., Wark, P., et al (2022). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2019: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 46. [More Information]
Norman, D., Cheng, A., Macartney, K., Moore, H., Danchin, M., Seale, H., Mcrae, J., Marshall, H., Buttery, J., Francis, J., et al (2022). Influenza hospitalizations in Australian children 2010–2019: The impact of medical comorbidities on outcomes, vaccine coverage, and effectiveness. Influenza and Other Respiratory Viruses, 16(2), 316-327. [More Information]
McRae, J., Dey, A., Carlson, S., Sinn, J., McIntyre, P., Beard, F., Macartney, K., Wood, N. (2022). Influenza vaccination among pregnant women in two hospitals in Sydney, NSW: what we can learn from women who decline vaccination. Public Health Research and Practice, 32(2). [More Information]
Carlson, S., Mcrae, J., Wiley, K., Leask, J., Macartney, K. (2022). Knowledge, attitudes and practices regarding influenza vaccination among parents of infants hospitalised for acute respiratory infection in Australia. Public Health Research and Practice, 32(4). [More Information]
Quinn, H., Comeau, J., Marshall, H., Elliott, E., Crawford, N., Blyth, C., Snelling, T., Richmond, P., Francis, J., Macartney, K., McIntyre, P., Wood, N. (2022). Pertussis Disease and Antenatal Vaccine Effectiveness in Australian Children. Pediatric Infectious Disease Journal, 41(3), 180-185. [More Information]
Mcrae, J., Blyth, C., Cheng, A., Quinn, H., Wood, N., Macartney, K. (2022). Preventing severe influenza in Australian infants: Maternal influenza vaccine effectiveness in the PAEDS-FluCAN networks using the test-negative design. Vaccine, 40(19), 2761-2771. [More Information]
Liu, B., Gidding, H., Stepien, S., Cretikos, M., Macartney, K. (2022). Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection. Vaccine, 40(43), 6288-6294. [More Information]
Saravanos, G., Hsu, P., Isaacs, D., Macartney, K., Wood, N., Britton, P. (2022). Respiratory Syncytial Virus-attributable Deaths in a Major Pediatric Hospital in New South Wales, Australia, 1998-2018. Pediatric Infectious Disease Journal, 41(3), 186-191. [More Information]
Mcrae, J., Blyth, C., Cheng, A., Quinn, H., Wood, N., Macartney, K. (2022). Risk factors and disease severity in Australian infants aged under 6 months hospitalised with influenza 2011–2019. Journal of Paediatrics and Child Health, 58(5), 848-855. [More Information]
Machalek, D., Vette, K., Collins, M., Carlin, J., Nicholson, S., Hirani, R., Irving, D., Gosbell, I., Gidding, H., Shilling, H., et al (2022). Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020. PloS One, 17(2024-07-07 00:00:00). [More Information]
Vette, K., Machalek, D., Gidding, H., Nicholson, S., O'Sullivan, M., Carlin, J., Downes, M., Armstrong, L., Beard, F., Dwyer, D., Quinn, H., Macartney, K., et al (2022). Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey. Open Forum Infectious Diseases, 9(3), ofac002. [More Information]
Sheel, M., Wood, N., Macartney, K., Buttery, J., Dinsmore, N., Marshall, H., Elliott, E., Kynaston, A., Richmond, P., Chateau, D., McIntyre, P. (2022). Severity of Rotavirus-Vaccine-Associated Intussusception: Prospective Hospital-Based Surveillance, Australia, 2007-2018. Pediatric Infectious Disease Journal, 41(6), 507-513. [More Information]
Deng, L., Macartney, K., Gill, D., Fathima, P., Wood, N., Gidding, H. (2022). Status epilepticus outcomes among vaccinated and unvaccinated children: A population-based study. Epilepsy and Behavior, 126, 1-9. [More Information]
Patel, C., Dey, A., Wang, H., McIntyre, P., Macartney, K., Beard, F. (2022). Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Final Report. Communicable Diseases Intelligence, 46. [More Information]
Begum, H., Dwyer, D., Holmes, M., Irving, L., Simpson, G., Senenayake, S., Korman, T., Friedman, N., Cooley, L., Wark, P., et al (2022). Surveillance for severe influenza and COVID-19 in patients admitted to sentinel Australian hospitals in 2020: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 46. [More Information]
Dey, A., Wang, H., Quinn, H., Pillsbury, A., Hickie, M., Deng, L., Wood, N., Beard, F., Macartney, K. (2022). Surveillance of adverse events following immunisation in Australia annual report, 2020. Communicable Diseases Intelligence, 46. [More Information]
Deng, L., Glover, C., Dymock, M., Pillsbury, A., Marsh, J., Quinn, H., Cashman, P., Snelling, T., Wood, N., Macartney, K. (2022). The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021. Medical Journal of Australia, 217(4), 195-202. [More Information]
Homaira, N., Binks, M., Walker, G., Larter, N., Clark, K., Campbell, M., McHugh, L., Briggs, N., Nyiro, J., Stelzer-Braid, S., Snelling, T., et al (2022). Transplacental transfer of RSV antibody in Australian First Nations infants. Journal of Medical Virology, 94(2), 782-786. [More Information]

show 25 more

2021

Stapelberg, N., Smoll, N., Randall, M., Palipana, D., Bui, B., Macartney, K., Khandaker, G., Wattiaux, A. (2021). A discrete-event, simulated social agent- based network transmission (DESSABNeT) model for communicable diseases: Method and validation using SARS-CoV-2 data in three large Australian cities. PloS One, 16(5 May). [More Information]
Strachan, R., Homaira, N., Beggs, S., Bhuiyan, M., Gilbert, G., Lambert, S., Macartney, K., Marshall, H., Martin, A., McCallum, G., Snelling, T., et al (2021). Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax, 76(5), 487-493. [More Information]
Tran, C., Chiu, C., Cheng, A., Crawford, N., Giles, M., Macartney, K., Blyth, C. (2021). ATAGI 2021 annual statement on immunisation Last updated: 19 September 2021. Communicable Diseases Intelligence, 45. [More Information]
Carlson, S., Quinn, H., Blyth, C., Cheng, A., Clark, J., Francis, J., Marshall, H., Macartney, K., Leask, J. (2021). Barriers to influenza vaccination of children hospitalised for acute respiratory illness: A cross-sectional survey. Journal of Paediatrics and Child Health, 57(3), 409-418. [More Information]
Fielding, J., Sullivan, S., Beard, F., Macartney, K., Williams, J., Dawson, A., Gilbert, G., Massey, P., Crooks, K., Moss, R., et al (2021). Constructing an ethical framework for priority allocation of pandemic vaccines. Vaccine, 39(5), 797-804. [More Information]
Qian, J., Banks, E., Macartney, K., Heywood, A., Lassere, M., Liu, B. (2021). Corticosteroid Use and Risk of Herpes Zoster in a Population-Based Cohort. Mayo Clinic Proceedings, 96(11), 2843-2853. [More Information]
McIntyre, P., Joo, Y., Chiu, C., Flanagan, K., Macartney, K. (2021). COVID-19 vaccines - Are we there yet? Australian Prescriber, 44(1), 19-25. [More Information]
Britton, P., Koirala, A., Wood, N., Macartney, K. (2021). COVID-19, children and schools: overlooked and at risk. Medical Journal of Australia, 214(4), 189-1.89E+03. [More Information]
Phillips, A., Carlson, S., Danchin, M., Beard, F., Macartney, K. (2021). From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years. Vaccine, 39(40), 5968-5981. [More Information]
Hull, B., Hendry, A., Dey, A., McIntyre, P., Macartney, K., Beard, F. (2021). Immunisation Coverage Annual Report 2018. Communicable Diseases Intelligence, 45, 1-38. [More Information]
Hull, B., Hendry, A., Dey, A., Macartney, K., Beard, F. (2021). Immunisation Coverage Annual Report 2019. Communicable Diseases Intelligence, 45, 1-38. [More Information]
Carlson, S., Blyth, C., Beard, F., Hendry, A., Cheng, A., Quinn, H., Leask, J., Macartney, K. (2021). Influenza disease and vaccination in children in Australia. Medical Journal of Australia, 215(2), 64-6.70E+02. [More Information]
Beard, F., Hendry, A., Macartney, K. (2021). Influenza vaccination uptake in Australia in 2020: impact of the COVID-19 pandemic? Communicable Diseases Intelligence, 45. [More Information]
Kerr, J., Macartney, K., Britton, P. (2021). Influenza-associated myositis: a single-centre, 5-year retrospective study. European Journal of Pediatrics, 180(2), 577-584. [More Information]
Koirala, A., Goldfeld, S., Bowen, A., Choong, C., Ryan, K., Wood, N., Winkler, N., Danchin, M., Macartney, K., Russell, F. (2021). Lessons learnt during the COVID-19 pandemic: Why Australian schools should be prioritised to stay open. Journal of Paediatrics and Child Health, 57(9), 1362-1369. [More Information]
Patel, C., Dalton, L., Dey, A., Macartney, K., Beard, F. (2021). Letter: Impact of the COVID-19 pandemic on pharmacist-administered vaccination services. Research in Social and Administrative Pharmacy, 17(1), 2040-2041. [More Information]
Wurzel, D., McMinn, A., Hoq, M., Blyth, C., Burgner, D., Tosif, S., Buttery, J., Carr, J., Clark, J., Cheng, A., Singh-Grewal, D., Wood, N., Macartney, K., Britton, P., et al (2021). Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: A national cohort study. BMJ Open, 11(11), e054510. [More Information]
Qian, J., Macartney, K., Heywood, A., Sheridan, S., Liu, B. (2021). Risk of recurrent herpes zoster in a population-based cohort study of older adults. Journal Of The American Academy Of Dermatology, 85(3), 611-618. [More Information]
Newall, A., Leong, R., Reyes, J., Curns, A., Rudd, J., Tate, J., Macartney, K., Parashar, U. (2021). Rotavirus vaccination likely to be cost saving to society in the United States. Clinical Infectious Diseases, 73(8), 1424-1430. [More Information]
Phillips, A., Glover, C., Leeb, A., Cashman, P., Fathima, P., Crawford, N., Snelling, T., Durrheim, D., Macartney, K. (2021). Safety of live attenuated herpes zoster vaccine in Australian adults 70-79 years of age: An observational study using active surveillance. BMJ Open, 11(3), e043880. [More Information]
Davies, C., Stoney, T., Hutton, H., Parrella, A., Kang, M., Macartney, K., Leask, J., McCaffery, K., Zimet, G., Brotherton, J., Skinner, R., et al (2021). School-based HPV vaccination positively impacts parents’ attitudes toward adolescent vaccination. Vaccine, 39(30), 4190-4198. [More Information]
Gidding, H., Machalek, D., Hendry, A., Quinn, H., Vette, K., Beard, F., Shilling, H., Hirani, R., Gosbell, I., Irving, D., O'Sullivan, M., Dwyer, D., Macartney, K., et al (2021). Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020. Medical Journal of Australia, 214(4), 179-185. [More Information]
Dey, A., Wang, H., Quinn, H., Pillsbury, A., Glover, C., Hickie, M., Wood, N., Beard, F., Macartney, K. (2021). Surveillance of adverse events following immunisation in Australia annual report, 2019. Communicable Diseases Intelligence, 45. [More Information]
Koirala, A., Wood, N., Macartney, K. (2021). Testing for SARS-CoV-2 infection: a key strategy to keeping schools and universities open. The Lancet Child and Adolescent Health, 5(6), 387-389. [More Information]
Hull, B., Hendry, A., Dey, A., Bryant, K., Radkowski, C., Pellissier, S., Macartney, K., Beard, F. (2021). The impact of the COVID-19 pandemic on routine vaccinations in Victoria. Medical Journal of Australia, 215(2), 83-84. [More Information]

show 22 more

2020

Glover, C., Crawford, N., Leeb, A., Wood, N., Macartney, K. (2020). Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. Vaccine, 38(31), 4892-4900. [More Information]
Top, K., Macartney, K., Bettinger, J., Tan, B., Blyth, C., Marshall, H., Vaudry, W., Halperin, S., McIntyre, P. (2020). Active surveillance of acute paediatric hospitalisations demonstrates the impact of vaccination programmes and informs vaccine policy in Canada and Australia. Eurosurveillance, 25(25), 1-12. [More Information]
Phillips, A., Hickie, M., Totterdell, J., Brotherton, J., Dey, A., Hill, R., Snelling, T., Macartney, K. (2020). Adverse events following HPV vaccination: 11 years of surveillance in Australia. Vaccine, 38, 6038-6046. [More Information]
Phillips, A., Hickie, M., Totterdell, J., Brotherton, J., Dey, A., Hill, R., Snelling, T., Macartney, K. (2020). Association between rotavirus vaccination and intussusception in Australian children: A record linkage study. Paediatric and Perinatal Epidemiology, 34(5), 6038-6046. [More Information]
Wood, N., Macartney, K., Leask, J., McIntyre, P. (2020). Australia needs a vaccine injury compensation scheme: Upcoming COVID-19 vaccines make its introduction urgent. Australian Journal of General Practice, 49. [More Information]
Rashid, H., Dey, A., Manocha, R., Tashani, M., Macartney, K., Beard, F. (2020). Australia's national zoster vaccination program: Knowledge, attitudes and behaviour of general practitioners. Communicable Diseases Intelligence, 44, 1-10. [More Information]
Patel, C., Beard, F., Hendry, A., Quinn, H., Dey, A., Macartney, K., Hueston, L., Dwyer, D., McIntyre, P. (2020). Australian mumps serosurvey 2012-2013: any cause for concern? Communicable Diseases Intelligence, 44, 1-23. [More Information]
Maguire, J., Beard, F., Méder, K., Dey, A., Macartney, K., McIntyre, P. (2020). Australian vaccine preventable disease epidemiological review series: invasive Haemophilus influenzae type b disease, 2000-2017. Communicable Diseases Intelligence, 44. [More Information]
Britton, P., Dale, R., Blyth, C., Clark, J., Crawford, N., Marshall, H., Elliott, E., Macartney, K., Booy, R., Jones, C. (2020). Causes and Clinical Features of Childhood Encephalitis: A Multicenter, Prospective Cohort Study. Clinical Infectious Diseases, 70(12), 2517-2526. [More Information]
Pillsbury, A., Fathima, P., Quinn, H., Cashman, P., Blyth, C., Leeb, A., Macartney, K. (2020). Comparative Postmarket Safety Profile of Adjuvanted and High-Dose Influenza Vaccines in Individuals 65 Years or Older. JAMA Network Open, 3(5), 1-13. [More Information]
Britton, P., Hu, N., Saravanos, G., Shrapnel, J., Davis, J., Snelling, T., Dalby-Payne, J., Kesson, A., Wood, N., Macartney, K., McCullagh, C., et al (2020). COVID-19 public health measures and respiratory syncytial virus. The Lancet Child and Adolescent Health, 4(11), e42-e43. [More Information]
Deng, L., Wood, N., Macartney, K., Gold, M., Crawford, N., Buttery, J., Richmond, P., Barton, B. (2020). Developmental outcomes following vaccine-proximate febrile seizures in children. Neurology, 95(3), E226-E238. [More Information]
Khatami, A., Burrell, R., McMullan, B., Rawlinson, W., Givney, R., Kok, J., Alexandersen, S., Jones, C., Macartney, K., Britton, P. (2020). Epidemic and Inter-epidemic Burden of Pediatric Human Parechovirus Infection in New South Wales, Australia, 2017-2018. Pediatric Infectious Disease Journal, 39(6), 507-511. [More Information]
Jayasinghe, S., Sheridan, S., Macartney, K. (2020). Herpes zoster vaccination in Australia: What’s available and who benefits? Australian Prescriber, 43(1), 2-6. [More Information]
Beard, F., Hendry, A., Macartney, K. (2020). Influenza vaccination uptake in our most vulnerable groups: how well are we protecting them in 2019? Communicable Diseases Intelligence, 44. [More Information]
Patel, C., Chiu, C., Beard, F., Crawford, N., Macartney, K. (2020). One disease, two vaccines: challenges in prevention of meningococcal disease. Medical Journal of Australia, 212(10), 453-456.e1. [More Information]
McRae, J., Quinn, H., Saravanos, G., Carlson, S., Britton, P., Crawford, N., Wood, N., Marshall, H., Macartney, K. (2020). Paediatric Active Enhanced Disease Surveillance (PAEDS) 2017 and 2018: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence, 44. [More Information]
Frank, O., De Oliveira Bernardo, C., Gonzalez-Chica, D., Macartney, K., Menzies, R., Stocks, N. (2020). Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Human Vaccines and Immunotherapeutics, 16(4), 965-971. [More Information]
Flanagan, K., Best, E., Crawford, N., Giles, M., Koirala, A., Macartney, K., Russell, F., Teh, B., Wen, S. (2020). Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines. Frontiers in Immunology, 11, 579250. [More Information]
Totterdell, J., Phillips, A., Glover, C., Chidwick, K., Marsh, J., Snelling, T., Macartney, K. (2020). Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data from Australia's MedicineInsight program. Vaccine, 38(23), 3968-3979. [More Information]
Marshall, H., Koehler, A., Wang, B., A'Houre, M., Gold, M., Quinn, H., Crawford, N., Pratt, N., Sullivan, T., Macartney, K. (2020). Safety of meningococcal B vaccine (4CMenB) in adolescents in Australia. Vaccine, 38(37), 5914-5922. [More Information]
Wnukowski-Mtonga, P., Jayasinghe, S., Chiu, C., Macartney, K., Brotherton, J., Donovan, B., Hall, M., Smith, D., Peterson, K., Campbell-Lloyd, S., et al (2020). Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Communicable Diseases Intelligence, 44. [More Information]
Damiano, J., Deng, L., Li, W., Burgess, R., Schneider, A., Crawford, N., Buttery, J., Gold, M., Richmond, P., Macartney, K., Wood, N., et al (2020). SCN1A variants in vaccine-related febrile seizures: a prospective study. Annals of Neurology, 87(2), 281-288. [More Information]
Dey, A., Wang, H., Quinn, H., Pillsbury, A., Glover, C., Hickie, M., Wood, N., Beard, F., Macartney, K. (2020). Surveillance of adverse events following immunisation in Australia: annual report, 2018. Communicable Diseases Intelligence, 44. [More Information]
Blyth, C., Cheng, A., Crawford, N., Clark, J., Buttery, J., Marshall, H., Francis, J., Mcrae, J., Kotsimbos, T., Kelly, P., Macartney, K. (2020). The impact of new universal child influenza programs in Australia: Vaccine coverage, effectiveness and disease epidemiology in hospitalised children in 2018. Vaccine, 38(13), 2779-2787. [More Information]
Li-Kim-Moy, J., Macartney, K. (2020). Time to prioritise influenza vaccination in pregnancy. The Lancet Infectious Diseases, 21(1), 8-10. [More Information]
Macartney, K., Quinn, H., Pillsbury, A., Koirala, A., Deng, L., Winkler, N., Katelaris, A., O'Sullivan, M., Dalton, C., Wood, N. (2020). Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study. The Lancet Child and Adolescent Health, 4(11), 807-816. [More Information]
Sullivan, S., Carlson, S., Cheng, A., Chilver, M., Dwyer, D., Irwin, M., Kok, J., Macartney, K., MacLachlan, J., Minney-Smith, C., et al (2020). Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Eurosurveillance, 25(47), 2001847. [More Information]
Hull, B., Beard, F., Hendry, A., Dey, A., Macartney, K. (2020). “No jab, no pay”: catch-up vaccination activity during its first two years. Medical Journal of Australia, 213(8), 364-369. [More Information]

show 26 more

2019

Hull, B., Hendry, A., Dey, A., Brotherton, J., Macartney, K., Beard, F. (2019). Annual Immunisation Coverage Report 2017. Communicable Diseases Intelligence, 43, 1-49. [More Information]
Carlson, S., Scanlan, C., Marshall, H., Blyth, C., Macartney, K., Leask, J. (2019). Attitudes about and access to influenza vaccination experienced by parents of children hospitalised for influenza in Australia. Vaccine, 37(40), 5994-6001. [More Information]
Macdonald-Laurs, E., Koirala, A., Britton, P., Rawlinson, W., Hiew, C., Mcrae, J., Dale, R., Jones, C., Macartney, K., McMullan, B., et al (2019). CSF neopterin, a useful biomarker in children presenting with influenza associated encephalopathy? European Journal of Paediatric Neurology, 23(1), 204-213. [More Information]
Beard, F., Hendry, A., Macartney, K. (2019). Early success with room for improvement: influenza vaccination of young Australian children. Medical Journal of Australia, 210(11), 484-486.e1. [More Information]
Chamings, A., Druce, J., Caly, L., Yoga, Y., Britton, P., Macartney, K., Alexandersen, S. (2019). Evolutionary analysis of human parechovirus type 3 and clinical outcomes of infection during the 2017-18 Australian epidemic. Scientific Reports, 9(1), 1-9. [More Information]
Cheng, A., Holmes, M., Dwyer, D., Senanayake, S., Cooley, L., Irving, L., Simpson, G., Korman, T., Macartney, K., Friedman, N., et al (2019). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2017: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 43, 1-17. [More Information]
Cheng, A., Holmes, M., Dwyer, D., Senanayake, S., Cooley, L., Irving, L., Simpson, G., Korman, T., Macartney, K., Friedman, N., et al (2019). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2018: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 43, 1-15. [More Information]
Blyth, C., Macartney, K., Mcrae, J., Clark, J., Marshall, H., Buttery, J., Francis, J., Kotsimbos, T., Kelly, P., Cheng, A. (2019). Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration. Clinical Infectious Diseases, 68(6), 940-948. [More Information]
Macartney, K. (2019). Long-term protection against varicella with two-dose combination measles-mumps-rubella-varicella vaccine. The Lancet Infectious Diseases, 19(3), 222-223. [More Information]
McRae, J., Quinn, H., Saravanos, G., McMinn, A., Britton, P., Wood, N., Marshall, H., Macartney, K. (2019). Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2016: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence, 43, 1-15.
Deng, L., Gidding, H., Macartney, K., Crawford, N., Buttery, J., Gold, M., Richmond, P., Wood, N. (2019). Postvaccination Febrile Seizure Severity and Outcome. Pediatrics, 143(5), 1-9. [More Information]
Saravanos, G., Sheel, M., Homaira, N., Dey, A., Brown, E., Wang, H., Macartney, K., Wood, N. (2019). Respiratory syncytial virus-associated hospitalisations in Australia, 2006-2015. Medical Journal of Australia, 210(10), 447-453. [More Information]
Qian, J., Heywood, A., Karki, S., Banks, E., Macartney, K., Chantrill, L., Liu, B. (2019). Risk of Herpes Zoster Prior to and Following Cancer Diagnosis and Treatment: A Population-Based Prospective Cohort Study. The Journal of Infectious Diseases, 220(1), 3-11. [More Information]
Maguire, J., Glasgow, K., Glass, K., Roczo-Farkas, S., Bines, J., Sheppeard, V., Macartney, K., Quinn, H. (2019). Rotavirus Epidemiology and Monovalent Rotavirus Vaccine Effectiveness in Australia: 2010-2017. Pediatrics, 144(44), 1-10. [More Information]
Marshall, H., Clarke, M., Heath, C., Quinn, H., Richmond, P., Crawford, N., Elliott, E., Toi, C., Kynaston, A., Booy, R., Macartney, K. (2019). Severe and complicated varicella and associated genotypes 10 years after introduction of a one-dose varicella vaccine program. The Journal of Infectious Diseases, 219(3), 391-399. [More Information]
Dey, A., Wang, H., Beard, F., Macartney, K., McIntyre, P. (2019). Summary of national surveillance data on vaccine preventable diseases in Australia, 2012-2015. Communicable Diseases Intelligence, 43, 1-99. [More Information]
Dey, A., Wang, H., Quinn, H., Hiam, R., Wood, N., Beard, F., Macartney, K. (2019). Surveillance of adverse events following immunisation in Australia annual report, 2017. Communicable Diseases Intelligence, 43, 1-30. [More Information]
Giles, M., Krishnaswamy, S., Macartney, K., Cheng, A. (2019). The safety of inactivated influenza vaccines in pregnancy for birth outcomes: a systematic review. Human Vaccines and Immunotherapeutics, 15(3), 687-699. [More Information]
Ioannides, S., Beard, F., Larter, N., Clark, K., Wang, H., Hendry, A., Hull, B., Dey, A., Chiu, C., Brotherton, J., Jayasinghe, S., Macartney, K., McIntyre, P. (2019). Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011-2015. Communicable Diseases Intelligence, 43, 1-109. [More Information]
Quinn, H., Gidding, H., Marshall, H., Booy, R., Elliott, E., Richmond, P., Crawford, N., McIntyre, P., Macartney, K. (2019). Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. Journal of Infection, 78(3), 220-225. [More Information]

show 17 more

2018

Pillsbury, A., Glover, C., Jacoby, P., Quinn, H., Fathima, P., Cashman, P., Leeb, A., Blyth, C., Gold, M., Snelling, T., Macartney, K. (2018). Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia. BMJ Open, 8(10), 1-11. [More Information]
Edirisuriya, C., Beard, F., Hendry, A., Dey, A., Gidding, H., Hueston, L., Dwyer, D., Wood, J., Macartney, K., McIntyre, P. (2018). Australian rubella serosurvey 2012-2013: On track for elimination? Vaccine, 36(20), 2794-2798. [More Information]
Sheel, M., Beard, F., Quinn, H., Dey, A., Kirk, M., Koehler, A., Markey, P., McIntyre, P., Macartney, K. (2018). Australian vaccine preventable disease epidemiological review series: varicella-zoster virus infections, 1998-2015. Communicable Diseases Intelligence, 42, 1-27.
Macartney, K., Phillips, A., Patel, C., Pillsbury, A., Brotherton, J. (2018). Authors' reply: Safety of Human Papillomavirus Vaccines. Drug Safety, 41(5), 541-543. [More Information]
Li-Kim-Moy, J., Wood, N., Jones, C., Macartney, K., Booy, R. (2018). Impact of Fever and Antipyretic Use on Influenza Vaccine Immune Reponses in Children. Pediatric Infectious Disease Journal, 37(10), 971-975. [More Information]
Alexander, K., Tong, P., Macartney, K., Beresford, R., Sheppeard, V., Gupta, M. (2018). Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection. Vaccine, 36(27), 3890-3893. [More Information]
Sheridan, S., Patel, C., Macartney, K., Cheng, A. (2018). New enhanced influenza vaccines for older Australians: what promise do they hold? Medical Journal of Australia, 209(3), 110-112.e1. [More Information]
Phillips, A., Patel, C., Pillsbury, A., Brotherton, J., Macartney, K. (2018). Safety of Human Papillomavirus Vaccines: An Updated Review. Drug Safety, 41(4), 329-346. [More Information]
Macartney, K., Gershon, A. (2018). Shingles vaccine after auto-HSCT decreases risk. The Lancet, 391(10135), 2082-2084. [More Information]
Dey, A., Wang, H., Quinn, H., Cook, J., Macartney, K. (2018). Surveillance of adverse events following immunisation in Australia annual report, 2016. Communicable Diseases Intelligence, 42(1), 11-8.
Patel, C., Brotherton, J., Pillsbury, A., Jayasinghe, S., Donovan, B., Macartney, K., Marshall, H. (2018). The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? Eurosurveillance, 23(41), 30-40. [More Information]
Phillips, A., Beard, F., Macartney, K., Chan, J., Gilmour, R., Saravanos, G., McIntyre, P. (2018). Vaccine-preventable child deaths in New South Wales from 2005 to 2014: How much is preventable? Journal of Paediatrics and Child Health, 54(4), 356-364. [More Information]

show 9 more

2017

Pillsbury, A., Quinn, H., Cashman, P., Leeb, A., Macartney, K. (2017). Active SMS-based influenza vaccine safety surveillance in Australian children. Vaccine, 35(51), 7101-7106. [More Information]
Reyes, J., Wood, J., Beutels, P., Macartney, K., McIntyre, P., Menzies, R., Mealing, N., Newall, A. (2017). Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. Vaccine, 35(2), 345-352. [More Information]
Khatami, A., Khan, F., Macartney, K. (2017). Enteric Fever in Children in Western Sydney, Australia, 2003-2015. Pediatric Infectious Disease Journal, 36(12), 1124-1128. [More Information]
Khandaker, G., Beard, F., Dey, A., Coulter, C., Hendry, A., Macartney, K. (2017). Evaluation of bacille Calmette-Guerin immunisation programs in Australia. Communicable Diseases Intelligence, 41(1), E33-E48.
Macartney, K., Gidding, H., Trinh, L., Wang, H., Dey, A., Hull, B., Orr, K., McRae, J., Richmond, P., Gold, M., McIntyre, P., Wood, N., et al (2017). Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia. JAMA Pediatrics, 171(10), 992-998. [More Information]
Deng, L., Macdougall, R., Macartney, K. (2017). Immunisation: It's not just for kids. Medicine Today, 18(6), 25-33.
Cheng, A., Holmes, M., Dwyer, D., Irving, L., Korman, T., Senenayake, S., Macartney, K., Blyth, C., Brown, S., Waterer, G., et al (2017). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2016: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence Quarterly Report, 41(4), E337-E347.
Li-Kim-Moy, J., Yin, K., Blyth, C., Kesson, A., Booy, R., Cheng, A., Macartney, K. (2017). Influenza hospitalizations in Australian children. Epidemiology and Infection, 145(7), 1451-1460. [More Information]
Britton, P., Dale, R., Blyth, C., Macartney, K., Crawford, N., Marshall, H., Clark, J., Elliott, E., Webster, R., Cheng, A., Booy, R., Jones, C. (2017). Influenza-associated Encephalitis/Encephalopathy Identified by the Australian Childhood Encephalitis Study 2013-2015. Pediatric Infectious Disease Journal, 36(11), 1021-1026. [More Information]
Trinh, L., Macartney, K., McIntyre, P., Chiu, C., Dey, A., Menzies, R. (2017). Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic General Practice data. Vaccine, 35(11), 1524-1529. [More Information]
Macartney, K., Crawford, N. (2017). Management and prevention of infectious diseases in IBD patients. In Daniel C. Baumgart (Eds.), Crohn's disease and ulcerative colitis: From epidemiology and immunobiology to a rational diagnostic and therapeutic approach. 2nd ed. Cham: Springer International Publishing. [More Information]
McRae, J., Quinn, H., Macartney, K. (2017). Paediatric Active Enhanced Disease Surveillance (PAEDS) annual report 2015: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence, 41(3), E280-E288.
Cashman, P., Macartney, K., Khandaker, G., King, C., Gold, M., Durrheim, D. (2017). Participant-centred active surveillance of adverse events following immunisation: A narrative review. International Health, 9(3), 164-176. [More Information]
Sheel, M., Beard, F., Dey, A., Macartney, K., McIntyre, P. (2017). Rates of hospitalisation for herpes zoster may warrant vaccinating indigenous Australians under 70. Medical Journal of Australia, 207(9), 395-396. [More Information]
Cheng, A., Macartney, K., Waterer, G., Kotsimbos, T., Kelly, P., Blyth, C. (2017). Repeated vaccination does not appear to impact on influenza vaccine effectiveness against hospitalisation with confirmed influenza. Clinical Infectious Diseases, 64(11), 1564-1572. [More Information]
Cheng, A., Macartney, K., Waterer, G., Kotsimbos, T., Kelly, P., Blyth, C. (2017). Reply to Skowronski and Chambers. Clinical Infectious Diseases, 65(2), 355. [More Information]
Patel, C., Macartney, K. (2017). Supporting the call for a gender-neutral human papillomavirus vaccination in Canada. CMAJ, 189(3), E118-E118. [More Information]
Dey, A., Wang, H., Quinn, H., Cook, J., Macartney, K. (2017). Surveillance of adverse events following immunisation in Australia, 2015. Communicable Diseases Intelligence, 41(3), E264-E278.
Yin, K., Heywood, A., Georgousakis, M., King, C., Chiu, C., Isaacs, D., Macartney, K. (2017). Systematic review and meta-analysis of indirect protection afforded by vaccinating children against seasonal influenza: Implications for policy. Clinical Infectious Diseases, 65(5), 719-728. [More Information]
Britton, P., Blyth, C., Macartney, K., Dale, R., Li-Kim-Moy, J., Khandaker, G., Crawford, N., Marshall, H., Clark, J., Elliott, E., Booy, R., Jones, C., et al (2017). The Spectrum and Burden of Influenza-Associated Neurological Disease in Children: Combined Encephalitis and Influenza Sentinel Site Surveillance from Australia 2013-2015. Clinical Infectious Diseases, 65(4), 653-660. [More Information]

show 17 more

2016

Hendry, A., Dey, A., Beard, F., Khandaker, G., Hill, R., Macartney, K. (2016). Adverse events following immunisation with bacille Calmette-Guerin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine. Communicable Diseases Intelligence Quarterly Report, 40(4), E470-E474.
Li-Kim-Moy, J., Yin, K., Patel, C., Beard, F., Chiu, C., Macartney, K., McIntyre, P. (2016). Australian vaccine preventable disease epidemiological review series: Influenza 2006 to 2015. Communicable Diseases Intelligence Quarterly Report, 40(4), E482-E495.
DeSilva, M., Munoz, F., Mcmillan, M., Kawai, A., Marshall, H., Macartney, K., Joshi, J., Oneko, M., Rose, A., Dolk, H., et al (2016). Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine, 34(49), 6015-6026. [More Information]
Wattiaux, A., Yin, K., Beard, F., Wesselingh, S., Cowie, B., Ward, J., Macartney, K. (2016). Hepatitis B immunization for indigenous adults, Australia. Bulletin of the World Health Organization, 94(11), 826-834A. [More Information]
Cheng, A., Holmes, M., Dwyer, D., Irving, L., Korman, T., Senenayake, S., Macartney, K., Blyth, C., Brown, S., Waterer, G., et al (2016). Influenza epidemiology in patients admitted to sentinel Australian hospitals in 2015: the Influenza Complications Alert Network. Communicable Diseases Intelligence Quarterly Report, 40(4), E521-E526.
Blyth, C., Macartney, K., Hewagama, S., Senenayake, S., Friedman, N., Simpson, G., Upham, J., Kotsimbos, T., Kelly, P., Cheng, A. (2016). Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: The influenza complications alert network (FluCAN). Eurosurveillance, 21(30), 1-9. [More Information]
Comeau, J., Chan, J., Macartney, K. (2016). New Vaccines on the Horizon. Current Pediatrics Reports, 4(3), 74-83. [More Information]
Zurynski, Y., McRae, J., Quinn, H., Wood, N., Macartney, K. (2016). Paediatric Active Enhanced Disease Surveillance inaugural annual report, 2014. Communicable Diseases Intelligence Quarterly Report, 40(3), E391-E400.
Britton, P., Dale, R., Nissen, M., Crawford, N., Elliott, E., Macartney, K., Khandaker, G., Booy, R., Jones, C. (2016). Parechovirus Encephalitis and Neurodevelopmental Outcomes. Pediatrics, 137(2), 1-11. [More Information]
Britton, P., Dale, R., Elliott, E., Macartney, K., Festa, M., Booy, R., Jones, C. (2016). Pilot surveillance for childhood encephalitis in Australia using the Paediatric Active Enhanced Disease Surveillance (PAEDS) network. Epidemiology and Infection, 144(10), 2117-2127. [More Information]
Dey, A., Wang, H., Quinn, H., Hill, R., Macartney, K. (2016). Surveillance of adverse events following immunisation in Australia annual Report, 2014. Communicable Diseases Intelligence, 40(3), E377-E390.
Li-Kim-Moy, J., Dastouri, F., Rashid, H., Khandaker, G., Kesson, A., McCaskill, M., Wood, N., Jones, C., Zurynski, Y., Macartney, K., Elliott, E., Booy, R. (2016). Utility of early influenza diagnosis through point-of-care testing in children presenting to an emergency department. Journal of Paediatrics and Child Health, 52(4), 422-429. [More Information]
Marshall, H., McMillan, M., Andrews, R., Macartney, K., Edwards, K. (2016). Vaccines in pregnancy: The dual benefit for pregnant women and infants. Human Vaccines and Immunotherapeutics, 12(4), 848-856. [More Information]

show 10 more

2015

Britton, P., Macartney, K., Arbuckle, S., Little, D., Kesson, A. (2015). A Rare Case of Q Fever Osteomyelitis in a Child From Regional Australia. Pediatric Infectious Diseases Society, 4(3), 28-31. [More Information]
Macartney, K., Gidding, H., Trinh, L., Wang, H., McRae, J., Crawford, N., Gold, M., Kynaston, J., Blyth, C., Zurynski, Y., Elliott, E., Booy, R., McIntyre, P., Wood, N., et al (2015). Febrile seizures following measles and varicella vaccines in young children in Australia. Vaccine, 33(11), 1412-1417. [More Information]
Davey, H., Muscatello, D., Wood, J., Snelling, T., Ferson, M., Macartney, K. (2015). Impact of high coverage of monovalent human rotavirus vaccine on Emergency Department presentations for rotavirus gastroenteritis. Vaccine, 33(14), 1726-1730. [More Information]
Cheng, A., Holmes, M., Senenayake, S., Dwyer, D., Hewagama, S., Korman, T., Irving, L., Brown, S., Waterer, G., Hunter, C., Macartney, K., et al (2015). Influenza epidemiology in adults admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Communicable Diseases Intelligence, 39(3), E355-E360.
Cheng, A., Kotsimbos, T., Kelly, P., Wark, P., Hunter, C., Hewagama, S., Friedman, D., Korman, T., Simpson, G., Dwyer, D., Macartney, K., et al (2015). Influenza vaccine effectiveness against hospitalisation with influenza in adults in Australia in 2014. Vaccine, 33(51), 7352-7356. [More Information]
Pillsbury, A., Cashman, P., Leeb, A., Regan, A., Westphal, D., Snelling, T., Blyth, C., Crawford, N., Wood, N., Macartney, K. (2015). Real-time safety surveillance of seasonal influenza vaccines in children, Australia, 2015. Eurosurveillance, 20(43), 6-10. [More Information]
Mahajan, D., Dey, A., Cook, J., Harvey, B., Menzies, R., Macartney, K. (2015). Surveillance of adverse events following immunisation in Australia annual report, 2013. Communicable Diseases Intelligence Quarterly Report, 39(3), e369-e386.
Li-Kim-Moy, J., Yin, K., Rashid, H., Khandaker, G., King, C., Wood, N., Macartney, K., Jones, C., Booy, R. (2015). Systematic review of fever, febrile convulsions and serious adverse events following administration of inactivated trivalent influenza vaccines in children. Eurosurveillance, 20(24), 1-20. [More Information]
Blyth, C., Cheng, A., Finucane, C., Jacoby, P., Effler, P., Smith, D., Kelly, H., Macartney, K., Richmond, P. (2015). The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia. Vaccine, 33(51), 7239-7244. [More Information]

show 6 more

2014

Quinn, H., Snelling, T., Macartney, K., McIntyre, P. (2014). Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics, 133(3), e513-e519. [More Information]
Beard, F., Macartney, K. (2014). Infants born in Australia to mothers from countries with a high prevalence of tuberculosis: to BCG or not to BCG? Medical Journal of Australia, 200(3), 149-149. [More Information]
Quinn, H., Wood, N., Cannings, K., Dey, A., Wang, H., Menzies, R., Moberley, S., Reid, S., McIntyre, P., Macartney, K. (2014). Intussusception after monovalent human rotavirus vaccine in Australia: Severity and comparison of using healthcare database records versus case confirmation to assess risk. Pediatric Infectious Disease Journal, 33(9), 959-965. [More Information]
Mahajan, D., Dey, A., Cook, J., Harvey, B., Menzies, R., Macartney, K. (2014). Surveillance of adverse events following immunisation in Australia, 2012. Communicable Diseases Intelligence Quarterly Report, 38(3), E232-E246.
Wood, N., Blyth, C., Willis, G., Richmond, P., Gold, M., Buttery, J., Crawford, N., Crampton, M., Yin, K., Chow, M., Macartney, K. (2014). The safety of seasonal influenza vaccines in Australian children in 2013. Medical Journal of Australia, 201(10), 596-600. [More Information]
Macartney, K., Heywood, A., McIntyre, P. (2014). Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews, 6, 1-45. [More Information]
Heywood, A., Wang, H., Macartney, K., McIntyre, P. (2014). Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bulletin of the World Health Organization, 92(8), 593-604. [More Information]

show 4 more

2013

Smith, B., Hazelton, B., Heywood, A., Snelling, T., Peacock, K., Macartney, K. (2013). Disseminated tuberculosis and tuberculous meningitis in Australian-born children; case reports and review of current epidemiology and management. Journal of Paediatrics and Child Health, 49(3), e246-e250. [More Information]
Jayasinghe, S., Macartney, K. (2013). Estimating rotavirus gastroenteritis hospitalisations by using hospital episode statistics before and after the introduction of rotavirus vaccine in Australia. Vaccine, 31(6), 967-972. [More Information]
Ward, K., Dey, A., Hull, B., Quinn, H., Macartney, K., Menzies, R. (2013). Evaluation of Australia's varicella vaccination program for children and adolescents. Vaccine, 31(10), 1413-1419. [More Information]
Hull, B., Menzies, R., Macartney, K., McIntyre, P. (2013). Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: The Australian experience. Vaccine, 31(15), 1964-1969. [More Information]
Dodd, C., Romio, S., Black, S., Vellozzi, C., Andrews, N., Sturkenboom, M., Zuber, P., Hua, W., Bonhoeffer, J., Buttery, J., Macartney, K., et al (2013). International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine, 31(40), 4448-4458. [More Information]
Carlin, J., Macartney, K., Lee, K., Quinn, H., Buttery, J., Lopert, R., Bines, J., McIntyre, P. (2013). Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Clinical Infectious Diseases, 57(10), 1427-1434. [More Information]
Cashmore, A., Muscatello, D., Merrifield, A., Spokes, P., Macartney, K., Jalaludin, B. (2013). Relationship between the population incidence of pertussis in children in New South Wales, Australia and emergency department visits with cough: A time series analysis. BMC Medical Informatics and Decision Making, 13(1), 1-11. [More Information]
Macartney, K., Chiu, C., Georgousakis, M., Brotherton, J. (2013). Safety of human papillomavirus vaccines: a review. Drug Safety, 36(6), 393-412. [More Information]
Wiley, K., Zuo, Y., Macartney, K., McIntyre, P. (2013). Sources of pertussis infection in young infants: A review of key evidence informing targeting of the cocoon strategy. Vaccine, 31(4), 618-625. [More Information]
Mahajan, D., Cook, J., Dey, A., Macartney, K., Menzies, R. (2013). Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2012. Communicable Diseases Intelligence Quarterly Report, 37(2), e130-e135. [More Information]

show 7 more

2012

Mahajan, D., Cook, J., Dey, A., Macartney, K., Menzies, R. (2012). Annual report: surveillance of adverse events following immunisation in Australia, 2011. Communicable Diseases Intelligence Quarterly Report, 36(4), E315-E332. [More Information]
Dey, A., Wang, H., Menzies, R., Macartney, K. (2012). Changes in hospitalisations for acute gastroenteritis in Australia after the national rotavirus vaccination program. Medical Journal of Australia, 197(8), 453-457. [More Information]
Khandaker, G., Zurynski, Y., Buttery, J., Marshall, H., Richmond, P., Dale, R., Royle, J., Gold, M., Snelling, T., Whitehead, B., Jones, C., Heron, L., Macartney, K., Elliott, E., Booy, R., et al (2012). Neurologic complications of influenza A(H1N1)pdm09: Surveillance in 6 pediatric hospitals. Neurology, 79(14), 1474-1481. [More Information]
Georgousakis, M., Jayasinghe, S., Brotherton, J., Gilroy, N., Chiu, C., Macartney, K. (2012). Population-wide vaccination against human papillomavirus in adolescent boys: Australia as a case study. The Lancet Infectious Diseases, 12(8), 627-634. [More Information]
Mahajan, D., Cook, J., McIntyre, P., Macartney, K., Menzies, R. (2012). Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011. Communicable Diseases Intelligence Quarterly Report, 36(1), 114-119. [More Information]

show 2 more

2011

Mahajan, D., Cook, J., McIntyre, P., Macartney, K., Menzies, R. (2011). Annual report: surveillance of adverse events following immunisation in Australia, 2010. Communicable Diseases Intelligence Quarterly Report, 35(4), 263-280. [More Information]
Macartney, K., Porwal, M., Dalton, D., Cripps, T., Maldigri, T., Isaacs, D., Kesson, A. (2011). Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. Journal of Paediatrics and Child Health, 47(5), 266-270. [More Information]
Georgousakis, M., Jelfs, J., Macartney, K. (2011). Immunisation for life: Don't forget adults. Medicine Today, 12(4), 29-37.
Macartney, K., Durrheim, D. (2011). NSW immunisation performance: continuing progress but no room for complacency. NSW Public Health Bulletin, 22(9-10), 169-170. [More Information]
Mahajan, D., Menzies, R., Cook, J., Macartney, K., McIntyre, P. (2011). Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010. Communicable Diseases Intelligence Quarterly Report, 35(1), 21-28. [More Information]

show 2 more

2010

Macartney, K. (2010). Heads Up: Monovalent polio vaccines are better. Journal of Paediatrics and Child Health, 46(5), 275.
McIntyre, P., Macartney, K., Gilroy, N., Lester, R. (2010). Immunisation. In A Yung, D Spelman, A Street, J McCormack, T Sorrell, P Johnson (Eds.), Infectious Diseases: A clinical approach, (pp. 648-666). Melbourne: IP Communications.
Macartney, K. (2010). Pertussis vaccination. Medicine Today, 11, 63-64.
Isaacs, D., Macartney, K., McIntyre, P. (2010). Rapid Response: Benefits and risks of childhood influenza vaccination. BMJ, , 1.
Webster, R., Hazelton, B., Suleiman, J., Macartney, K., Kesson, A., Dale, R. (2010). Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports. Neurology, 74(13), 1077-1078. [More Information]
Chiu, C., Dey, A., Wang, H., Menzies, R., Deeks, S., Mahajan, D., Macartney, K., Jardine, A., Quinn, H., Jelfs, J., Booy, R., Lawrence, G., Wood, N., McIntyre, P., et al (2010). Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence Quarterly Report, 34, S1-167. [More Information]

show 3 more

2009

Wood, J., Gidding, H., Heywood, A., Macartney, K., McIntyre, P., MacIntyre, C. (2009). Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Vaccine, 27(2), 313-318. [More Information]
Macartney, K., Burgess, M. (2009). Rapid impact of rotavirus vaccination in the United States: implications for Australia. Medical Journal of Australia, 191(3), 131-132. [More Information]
Macartney, K. (2009). What's new in childhood immunisation? Medicine Today, 10, 24-30.

2008

Wood, J., MacIntyre, R., Macartney, K. (2008). Assessing varicella vaccine efficacy. Pediatric Infectious Disease Journal, 27(2), 190; author reply 190-1. [More Information]
Leask, J., Quinn, H., Macartney, K., Trent, M., Massey, P., Carr, C., Turahui, J. (2008). Immunisation attitudes, knowledge and practices of health professionals in regional NSW. Australian and New Zealand Journal of Public Health, 32(3), 224-229. [More Information]
Leask, J., Macartney, K. (2008). Parental decisions about vaccination: Collective values are important. Journal of Paediatrics and Child Health, 44(10), 534-535. [More Information]
Inglis, E., Kesson, A., Newell, A., Macartney, K., MacIntyre, C. (2008). The burden of rotavirus gastroenteritis in children presenting to a paediatric hospital. Epidemiology and Infection, 137(7), 943-949. [More Information]
Macartney, K., McIntyre, P. (2008). Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults. Cochrane Database of Systematic Reviews, 2008 (3), CD001833-1-CD001833-27. [More Information]
Macartney, K., Burgess, M. (2008). Varicella vaccination in Australia and New Zealand. The Journal of Infectious Diseases, 197, S191-5. [More Information]

show 3 more

2007

Macartney, K., MacIntyre, C., McIntyre, P. (2007). Current developments in varicella-zoster virus disease prevention. A report on the varicella-zoster virus workshop convened by the National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases on 16-17 November 2006. Communicable Diseases Intelligence Quarterly Report, 31(3), 303-310. [More Information]
Newall, A., Beutels, P., Macartney, K., Wood, J., MacIntyre, C. (2007). The cost-effectiveness of rotavirus vaccination in Australia. Vaccine, 25, 8851-8860. [More Information]
Brotherton, J., Wang, H., Schaffer, A., Quinn, H., Menzies, R., Hull, B., Lawrence, C., Wood, J., Wood, N., Rosewell, A., Newall, A., Macartney, K., Gidding, H., McIntyre, P., Booy, R., et al (2007). Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005. Communicable Diseases Intelligence Quarterly Report, 31(Suppl June 2007), 1-152. [More Information]

2006

Newall, A., MacIntyre, C., Wang, H., Hull, B., Macartney, K. (2006). Burden of severe rotavirus disease in Australia. Journal of Paediatrics and Child Health, 42(9), 521-527. [More Information]

2005

Macartney, K., McIntyre, P. (2005). Universal varicella vaccination. Comment. Medical Journal of Australia, 183(5), 278-9. [More Information]
Macartney, K., Beutels, P., McIntyre, P., Burgess, M. (2005). Varicella vaccination in Australia. Journal of Paediatrics and Child Health, 41(11), 544-552. [More Information]

Selected Grants

2022

Vaccine effectiveness against Omicron SARS-CoV-2 variant in NSW using linked data, Macartney K, Gidding H, NSW Health/COVID-19 Emergency Response Priority Research Support Program

2021

Australian Expert Technical Assistance Program for Regional COVID-19 Vaccine Access Policy, Planning and Implementation (AETAP-PPI), Macartney K, Department of Foreign Affairs and Trade (Federal)/Research Support
Monitoring and Investigating the Safety and Effectiveness of The Covid-19 Vaccination Program, Macartney K, NSW Health/Covid-19 Research Grant
COVID-19 Schools and Early Childhood Education and Care Services Transmission Investigation Project Continuation, Macartney K, Wood N, Koirala A, NSW Health/Covid-19 Research Grant
Designing and testing COVID-19 vaccine public health messages for key target audiences, Macartney K, Leask J, Beard F, Koo F, Bolsewicz K, Steffens M, Bullivant B, Clark K, Crooks K, Seale H, NSW Health/Covid-19 Research Grant

2020

BEAT COVID, Sorrell T, Ward R, Snelling T, Snelling T, Nicholson A, Grieve S, Macartney K, O'Sullivan M, Thevarajan I, Bull R, Britton P, Cunningham A, Eden J, Smith D, Imrie A, Tang B, Brilot-Turville F, Snow Medical Research Foundation Ltd/Pandemic Response Capacity Building

2019

B Part of It NT: Immunisation for adolescents against serious communicable diseases, Macartney K, Marshall H, National Health and Medical Research Council (NHMRC)/Partnership Projects

2016

Reducing vaccine preventable diseases in children: using national active hospital-based surveillance to evaluate and improve immunisation program performance, Macartney K, Blyth C, Marshall H, Leask J, McIntyre P, Elliott E, Snelling T, Clark J, Buttery J, Wood N, National Health and Medical Research Council (NHMRC)/Partnership Projects
Australian Partnership for Preparedness Research on InfectiouS disease Emergencies APPRISE, Lewin S, Sorrell T, Dawson A, Gilbert G, Macartney K, National Health and Medical Research Council (NHMRC)/Centres of Research Excellence

2012

Febrile seizures following vaccination in children: How common are they and what is the long term clinical outcome, Wood N, Buttery J, Gold M, Richmond P, Crawford N, Barton B, Macartney K, National Health and Medical Research Council (NHMRC)/Project Grants

Faculty of Medicine and Health

Page not found

Professor Kristine Macartney

Publications

By Type

By Year

Selected Grants

2022

2021

2020

2019

2016

2012

Related research articles

Sydney experts elected to Academy of Health and Medical Sciences

Covid report on Delta and Omicron variants in education settings

How our experts shaped the COVID19 response

COVID-19 Delta variant in education settings: new report

Sydney experts spearheads COVID19 vaccine research

How will we know COVID vaccines are safe

Antibody study confirms low levels of infection during first wave

Expert alliance to support improved immunisation in Indo Pacific

COVID 19 study confirms low transmission in educational settings

COVID 19 research funding boosts Sydney led projects

Are you up to date with your vaccinations?

Thinking about getting your child the flu vaccine?

Report on vaccine preventable deaths a reminder to parents

Combination vaccines do not overwhelm kids’ immune systems

The flu vaccine is more important than you think